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Metabolic imbalance is a problem in the dairy industry because the metabolic 
demands of increased milk production can lead to decreased fertility, and more 
knowledge about improving the management and physical conditions of the cow 
(the links between fertility, nutrition, milking, and dry period) is needed. Insulin 
is an important hormone regulating the energy balance in the body, and insulin 
concentrations change in situations of energy deficiency or excess, both of which 
are known to decrease fertility in cows as well as in humans. Hyperinsulinemia 
is associated with decreased fertility by impairing the developmental potential 
of embryos, but the underlying reasons for this remain unclear. Our aim was to 
investigate insulin-induced changes on development, morphology and molecular 
signature in bovine blastocysts on Day 8 (BC8).  
An in vitro model was used and morphology and gene expression were 
analysed by combining confocal microscopy and microarray-based 
transcriptome studies. Blastocysts were produced in vitro according to standard 
methods using oocytes that were supplemented with three different insulin levels 
(INS10 =10 g/ml; INS0.1= 0.1 g/ml; INS0=control) during maturation. The 
transcriptome profile of BC8 was obtained and embryo quality grades, 
developmental stages and morphologies were further assessed in terms of F-
actin, DNA, and active mitochondria. Significant differences were observed in 
developmental rates and morphology after insulin exposure. The observed 
changes were reflected by increased expression of genes involved in cell division 
and structure, mitochondrial activation, lipid metabolism, and oxidative stress. 
Combining all of the results, it was shown that elevated insulin impairs the 
developmental potential of the embryo. This work contributes to new knowledge 
about the molecular background of embryos developing under metabolic stress 
conditions such as hyperinsulinemia. Moreover, the studies are of comparative 
value for humans where impaired fertility is often related to metabolic disorders.  
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1.1 Bovine reproduction and metabolic disorders 
Reproductive performance is a key factor for cost efficiency in the dairy industry 
and cow reproduction and early embryonic development are well-studied topics. 
The oocyte matures in the follicle surrounded by follicular fluid, and this process 
is influenced by metabolic and nutritional changes in the blood (Leroy et al., 
2004, 2011; Aardema et al., 2013). The concentrations of these metabolites 
might differ significantly depending on the maternal nutritional state. The oocyte 
appears to be very sensitive to metabolic stress, which might decrease its 
developmental potential. Moreover, there is even a risk that the offspring of an 
obese mother later in life will suffer from metabolic diseases because metabolic 
programming occurs early in life through epigenetic changes that can remain 
throughout the entire life (Heerwagen et al., 2010).  
Follicular growth and oocyte maturation takes 8 -12 weeks in the dairy cow 
(Beam & Butler, 1997, 1999). This means that the oocyte in the growing follicle 
that will be subjected to the first inseminations after parturition undergoes 
several metabolically challenging periods until final maturation. Often, dairy 
cows are over-conditioned in the dry period (Rukkwamsuk et al., 1999), which 
leads to elevated circulating insulin levels and impaired insulin sensitivity 
(Locher et al., 2015). After calving, the metabolic profile of dairy cows changes 
due to the increasing energy demands for milk production (Fleischer et al., 
2001). Most dairy cows go through a period of negative energy balance while 
insulin levels are low (Butler et al., 2004), and non-esterified fatty acid (NEFA) 
concentrations are elevated due to lipid mobilization (Bossaert et al., 2008). The 
dairy cow suffers from ketosis, a state during which ȕ-hydroxybutyric acid levels 
are increased, a sign for severe energy deficiency leading to secondary diseases 
due to immune system deficiencies (Ingvartsen, 2006). Circulating insulin levels 
1 Introduction 
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increase when positive energy balance is restored (Gong et al., 2002; Humblot 
et al., 2008), and this has positive effects on reproductive functions. This switch 
from energy excess to energy deficiency might negatively affect the 
developmental competence of the oocyte because the oocyte metabolism and 
gene expression have to be well balanced to allow for optimal oocyte 
development during that time period (Leroy et al., 2011). It is known that 
subfertile dairy heifers rapidly gain weight and become overconditioned after a 
period of repeated, unsuccessful inseminations (Gustafsson, 1985). These 
heifers are characterized by hormonal aberrations and by impaired oocyte 
quality and reduced early embryonic developmental competence (Båge, 2002; 
Båge et al., 2003; Awasthi et al., 2010). If fat heifers finally manage to conceive, 
they will be at high risk of dystocia at parturition along with retained placenta 
and metritis, which in turn will increase the risk for fertility problems in the 
insemination period.  
It has become evident that both increases and decreases in circulating insulin 
levels have a potential role in the health of the embryo developing under such 
conditions. 
Moreover, similarities between the human and bovine species provide a 
fruitful research field because new insights in the relation between metabolic 
and reproductive disorders could help to improve fertility in both species. The 
suitability of a bovine model for human embryonic development can be 
explained by analogies in ovarian reserve, follicular dynamics and embryonic 
metabolism (Ménézo & Hérubel, 2002; Campbell et al., 2003a). 
1.2 Insulin 
The hormone insulin was discovered in 1921 by Banting and Macleod and this 
marked a major breakthrough in medicine (Quianzon & Cheikh, 2012). Long 
before that, it was already hypothesized that there must be a substance secreted 
by the pancreas controlling carbohydrate metabolism (Bliss, 1993). Macleod 
isolated insulin from cow pancreases, and the first diabetic patient was 
successfully treated in 1922. Since then, insulin has been in focus for 
understanding the pathophysiological mechanisms of diabetes and related 
diseases, and the successful therapy of patients suffering from diabetes was 
honoured with the Nobel Prize in 1922. 
Insulin is a peptide hormone produced by the ȕ-cells in the islets of 
Langerhans (Sonksen & Sonksen, 2000), and it functions as a key metabolic 
regulator of energy homeostasis in the body. Insulin acts on multiple levels of 
lipid and glucose metabolism (Saltiel & Kahn, 2001), and its metabolic effects 
include stimulation of DNA synthesis, protein synthesis, transmembrane 
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transport, and lipogenesis (Kahn & White, 1988). Insulin is proteolytically 
converted from its precursor polypeptides in several steps, and the final 
activation step occurs by cleaving C-peptide from proinsulin (Steiner, 2008). 
The biologically active insulin molecule consists of 51 amino acids forming the 
A and B chain that are connected via three disulphide bridges (Brange & 
Langkjœr, 1993). Insulin is highly evolutionarily conserved in its structure 
among species; for example, bovine and human insulin only differ in three amino 
acid residues (Smith, 1966). 
The interest in understanding the action and regulation of insulin has not 
decreased in recent years, and research on insulin is still of high relevance 
because diabetes and diabetes-related diseases are increasing worldwide 
(Seidell, 2000). Knowing about the importance and history of insulin explains 
our aim to contribute with our research to add one more piece to the puzzle in 
better understanding insulin-related pathways during early embryonic 
development. 
1.2.1  Insulin receptor signalling and functions  
Insulin action is transmitted through its binding with different affinities to both 
the insulin receptor and the related insulin-like growth factor (IGF)-1 receptor 
(Rechler & Nissley, 1985). The insulin receptor belongs to the family of ligand-
activated receptors with tyrosine kinase activity, and it contains transmembrane 
signalling domains with two alpha and two beta chains (Lee & Pilch, 1994). 
Both insulin and IGF receptors auto-phosphorylate tyrosine residues on the 
receptor upon ligand binding, and their biological response is transmitted by 
phosphorylation of intracellular proteins that activate different signalling 
cascades (Sibley et al., 1987; Häring, 1991; Tsakiridis et al., 1999). 
Two main intracellular pathways lead to either metabolic or mitogenic post-
receptor actions through mitogen activated protein kinase (MAPK) or 
phosphatidyl-inositol-3-kinase (PI3K) (Shepherd et al., 1998; Figure 1, 
schematic illustration). In brief, insulin binding activates the insulin receptor 
tyrosine kinase to phosphorylate insulin receptor substrates (IRSs). IRS proteins 
are recruited to the receptor and phosphorylated on tyrosine residues, leading to 
binding sites for molecules with a Src-homology 2 (SH2) domain such as PI3K 
(Myers et al., 1992), Shc –proteins, and growth factor receptor-bound protein 2 
(GRB2) (Pelicci et al., 1992; Sasaoka et al., 1994; Sun et al., 1997; Boucher et 
al., 2014). Activated PI3K generates phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) from phosphatidylinositol 4,5-bisphosphate (PIP2), and this second 
messenger leads to an activation cascade of different protein kinases, especially 
protein kinase B (PKB/Akt), a serine kinase. PKB is involved in the translocation 
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of glucose transporter type 4 (GLUT-4) vesicles to the cell membrane, the most 
well-studied insulin action allowing glucose uptake. PKB also leads to increased 
protein synthesis (Pessin & Saltiel, 2000; Bevan, 2001; Lizcano & Alessi, 2002).  
The signal transduction proteins leading to mitogenic functions are GRB2, a 
protein with SH2 and SH3 domains, and Shc (Pelicci et al., 1992; Sasaoka et al., 
1994; Chow et al., 1998). Shc proteins are able to bind GRB2 after tyrosine 
phosphorylation which leads to activation of Ras and, the beginning of a 
phosphorylation cascade and the consequent activation of MAPKs (Giorgetti et 
al., 1994). MAPKs are proteins involved in the regulation of cell growth, 
division, and apoptosis and are able to phosphorylate nuclear proteins and 
several protein kinases that interact with transcription factors and thus influence 
gene expression (Sturgill et al., 1988; Bevan, 2001; Hilger et al., 2002). 
 
Figure 1. Insulin signalling pathway (described in detail in text).  
Akt/PKB = Protein Kinase B, GRB-2 = Growth factor receptor-bound protein 2, IRS = Insulin receptor substrate, 
MAPK = mitogen-activated protein kinase, MEK = Mitogen-activated protein kinase kinase, P = Tyrosine 
phosphorylated state, PI3K = Phosphatidylinositol-4,5-bisphosphate 3-kinase, PIP2 = Phosphatidylinositol 4,5-
bisphosphate, PIP3 = Phosphatidylinositol (3,4,5)-trisphosphate, Raf = Rapidly accelerated fibrosarcoma, Ras = 
Ras protein, SH2 = Src homology 2 domain-containing, ShC = ShC protein, SoS = son of sevenless, *activated 
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1.2.2 The role of insulin in the metabolism of ruminants 
The different functions of insulin are tissue-specific, and the induced post- 
receptor mechanisms and responses differ in liver, adipose tissue, and skeletal 
muscle (Zachut et al., 2013). In contrast to humans, the glucose metabolism of 
ruminants is not entirely dependent of insulin, and only a limited amount of the 
available glucose derives from direct intestinal absorption (Aschenbach et al., 
2010). In general, peripheral glucose concentrations are lower and insulin 
responses are weaker in ruminants (Kaske et al., 2001). Even if the same 
mechanisms – including insulin-induced translocation of the glucose transporter 
GLUT4 towards the cell membrane to facilitate the glucose uptake in the cell –  
exist, lower GLUT4 and IRS-1 availability lead to a weaker response of glucose 
metabolism to insulin stimuli (Sasaki, 2002). Thus, only a small amount of 
glucose is used for lipogenesis in the adipose tissue, which uses acetate as a 
preferred substrate for lipid synthesis (Hanson & Ballard, 1967).  
The glucose uptake in the mammary gland can be up to 92% of the total 
glucose consumption (Rose et al., 1997). In the mammary gland, glucose uptake 
is independent of insulin signalling, and GLUT4 is not detectable (Komatsu et 
al., 2005), and this is further evidence for the tissue specific characteristics of 
insulin and glucose metabolism. 
Different from humans, the glucose requirements of ruminants must always 
– not just during fasting  – be covered by gluconeogenesis from non-
carbohydrate sources. The most abundant substrates derive from microbial 
activity in the rumen in form of short fatty acids (Brockman, 1978; Brockman & 
Laarveld, 1986) that are synthesized to glucose in the intermediate metabolism. 
The regulation of catabolic and anabolic actions is transmitted through glucagon 
and insulin where the major glucogenic substrates are propionate, lactate, 
pyruvate, amino acids and glycerol (Bergman, 1973). Propionate and other 
short-chained fatty acids and lactate have their origin in microbial fermentation. 
Lactate can originate from anaerobic glucose oxidation while glycerol together 
with NEFAs originate from fat mobilization (De Koster & Opsomer, 2013).  
Insulin stimulates glucose uptake in muscle cells and adipose tissue, while 
glucagon has its primary target in the liver to stimulate gluconeogenesis 
(Brockman, 1978). The insulin response in different tissues varies through 
insulin receptor and GLUT4 availability, which changes during different periods 
of lactation. One explanation for this regulatory system is that glucose demands 
vary significantly depending on milk production and can increase up to four fold 
from late pregnancy to early lactation (Bell, 1995). The metabolism needs to 
adapt to the varying requirements by increasing expression of gluconeogenic 
enzymes in the liver (Graber et al., 2010). At the same time, insulin stimulation 
is reduced (due to low circulating insulin levels postpartum or due to peripheral 
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insulin resistance) which leads to lipid mobilization and thus higher availability 
of substrates important for gluconeogenesis. 
At the hepatic level, elevated insulin decreases glycogenolysis, i.e. the 
conversion of glycogen to glucose-6-phosphate, and decreases lipolysis, while it 
increases glycogen synthesis (Donkin & Armentano, 1995). This is due to the 
fact that the energy substrate availability is sufficient in the presence of high 
insulin concentrations, and this is a condition in which storage of energy would 
be favourable (McDowell, 1983). Some studies report a suppressive effect of 
insulin on gluconeogenesis (Donkin & Armentano, 1995; De Koster and 
Opsomer, 2013), while other authors state that gluconeogenesis from propionate 
is less regulated by insulin but mainly dependent on feed intake (Brockman, 
1978; Danfær et al., 1995). This makes sense because in ruminants, glucose has 
to be synthesised from its precursors, even in situations with high substrate 
availability. 
1.2.3 Insulin and metabolic imbalance 
Circulating levels of insulin serve as an indicator of energy balance in the body. 
Situations with short or long term hyper- or hypoinsulinemia exist in cattle as 
well as in other mammals including humans (Butler et al., 2003; Eckel et al., 
2005).  
In humans, the incidence of obesity, metabolic syndrome, and type 2 diabetes 
is increasing, all of which are examples of hyperinsulinemic conditions 
associated with positive energy balance (PEB)(Seidell, 2000). In the dairy cow, 
PEB is often maintained during the dry period when the cow is not lactating 
(Holtenius et al., 2003), implying a risk of developing obesity. The change from 
PEB to negative energy balance (NEB) is especially dramatic in cows in good 
body condition, and many cows fail to adapt to the transition from an anabolic 
situation during the dry period to a catabolic postpartum condition (Roche et al., 
2000). The failure of adapting to the increasing energy demands for lactation 
leads to ketosis. It is possible to distinguish two different types of ketosis, e.g. 
using existing differences regarding the insulin levels measured in blood (Herdt, 
2000; Oetzel, 2007). In brief, ketosis 1 or “underfeeding ketosis” often occurs 3 
-6 weeks after calving at the peak of lactation and in thin animals, while ketosis 
2 is present in fat cows and involves liver pathologies due to fat accumulation. 
Ketosis 2 occurs one or two weeks after calving, with an initial depression in 
food intake followed by fat mobilization, and it has a poorer prognosis than 
ketosis 1. This “fat cow syndrome” type of ketosis has similarities to type 2 
diabetes in humans because the glucose and insulin levels initially are high and 
insulin sensitivity low, and this leads to the development of insulin resistance 
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(Oetzel, 2007). Interestingly, different cow breeds show variation concerning 
their sensitivity to metabolic perturbations and in how quickly PEB can be 
restored (O’Hara et al., 2016; Ntallaris et al., 2017), and there are strategies to 
change feeding regimes to avoid the negative effect of low insulin and glucose 
levels (Holtenius et al., 1996; Gong et al., 2002).  
In conclusion, insulin-raising feeding regimes have a beneficial effect on cow 
health, while fat supplementation should be avoided because it decreases feed 
intake and is unfavourable for metabolic functions because lipid metabolism is 
already overloaded by lipids from body fat mobilization. Insulin is an important 
regulator of the growth hormone – insulin-like growth factor (GH-IGF) axis and 
thus has a role in lipid mobilization. It stimulates hepatic expression of GH 
receptors and IGF-1, which leads to high peripheral IGF-1 concentrations, while 
it inhibits GH receptors and IGF-1 in adipocytes (Butler et al., 2003). High 
circulating levels of IGF-1 and insulin reduce circulating GH concentrations 
which reduces lipolytic mobilization of body energy reserves. This is the reason 
why it is beneficial to feed diets that increase circulating insulin levels after 
calving, thus reducing the negative cascade of metabolic disturbances linked to 
lipid breakdown. During situations of NEB (Lucy, 2006; Kawashima et al., 
2007), such as in early lactation of the dairy cow or other conditions when energy 
intake is lower than energy requirements for maintaining body functions and all 
physical activity, the opposite occurs and increasing GH concentrations lead to 
lipid mobilization while insulin is low. Metabolic stress conditions in the form 
of energy excess or deficiency have shared metabolic characteristics. The 
elevated levels of lipids in the blood can be dietary induced or can develop 
through fat mobilization (Leroy et al., 2015). The over-conditioned cow in the 
dry period has a greater risk of suffering from NEB and secondary diseases after 
parturition, and this is why the extreme and abrupt change from PEB to NEB is 
reported to be a high stress factor that the individual has to cope with 
(Rukkwamsuk et al., 1999). Insulin functions in carbohydrate and lipid 
metabolism are well studied and described (Saltiel & Kahn, 2001), but the 
consequences of elevated insulin exposure during early development might 
differ from its effects on differentiated tissues such as the liver, adipose tissue 
and intestine. Oxidative stress and mitochondrial damage have been described 
in the context of metabolic stress (Ceriello & Motz, 2004; Furukawa et al., 2004; 
Roberts & Sindhu, 2009; Wu et al., 2015) and might thus also be one explanation 
for the detrimental effect of changes related to elevated insulin concentrations 
during oocyte maturation (Figure 2). 
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Figure 2. Involvement of ROS in mitochondrial dysfunction and insulin resistance. 
ROS = Reactive oxygen species, IRS = Insulin receptor substrate, H2O2 = Hydrogen peroxide, PTPase = 
Tyrosine-specific protein phosphatases, DG = Diacylglycerol, LCFA-CoA = Long-chain acyl-CoA, TFN = 
tumour necrosis factor, NEFA = Non-esterified fatty acids. 
1.2.4 Insulin resistance 
Insulin resistance is the state when physiological concentrations of insulin no 
longer lead to normal responses in the target cells (Kahn, 1978).  
It is important to be aware that insulin resistance can be tissue-specific and a 
transient condition in the dairy cow (Kahn, 1978; Muniyappa et al., 2008). The 
most well-described form of “classical“ insulin resistance is the reduced 
sensitivity of muscle and adipose tissue which can occur during pregnancy, 
obesity, and type 2 diabetes in humans (Häring, 1991; Pessin & Saltiel, 2000). 
In the dairy cow, insulin resistance is most common during late pregnancy and 
early lactation, most probably linked to hormonal and metabolic changes during 
lactation where glucose is the favourable substrate for the udder (Bell & 
Bauman, 1997). Moreover, this natural regulation mechanism might coincide 
with a massive increase in NEFAs which are thought to reduce insulin sensitivity 
and furthermore contribute to insulin resistance in the peripartum period 
(Oikawa & Oetzel, 2006; Pires et al., 2007) by IRS-1 phosphorylation (Le 
Marchand-Brustel et al., 2003). 
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The insulin receptor expression pattern is regulated in a similar way in all 
insulin sensitive tissue types, and insulin exposure leads to receptor 
downregulation that is regenerated within four hours after the end of insulin 
exposure (Marshall & Olefsky, 1981). This might be one of the 
pathophysiological mechanisms of insulin resistance in chronic 
hyperinsulinemia where the physiological receptor regeneration no longer 
occurs (Wigand & Blackard, 1979). The mechanisms that are involved in 
deactivating insulin action are very important for controlling metabolic 
pathways. Here, phosphatases are described as the main players to 
dephosphorylate the tyrosine on the activated receptor and IRS (Goldstein et al., 
1998). 
Other factors that are known to participate in decreased insulin sensitivity are 
increased circulating NEFAs, hormones, proinflammatory cytokines, and 
reactive oxygen species (ROS), all of which are present in obese conditions and 
are involved in detrimental actions on post-receptor cascades (Reaven et al., 
1988; Boden, 1997; Houstis et al., 2006; Shoelson et al., 2006). One mechanism 
of insulin resistance at the post-receptor level is serine/threonine 
phosphorylation of insulin IRS-1 and 2 instead of tyrosine phosphorylation, 
which leads to reduced activation of PI3K and the subsequent glucose transport 
activation steps (Figure 3 and Czech & Corvera, 1999; Farese, 2002). 
Accumulation of lipids – both if originating from nutritional sources (PEB, 
overfeeding, obesity) or from body-fat breakdown (NEB) – has toxic effects 
(“lipotoxicity”). Interestingly, overconditioned subfertile heifers not only have 
an excess of subcutaneous fat, but they also have a parallel, detrimental 
accumulation of fat in their oocytes (Awasthi et al., 2010). Lipotoxicity can 
explain some mechanisms responsible for insulin resistance, and increased fatty 
acid accumulation in the cell can directly reduce insulin sensitivity. In addition 
to this direct effect, increased lipid influx can also indirectly contribute to insulin 
resistance by inducing oxidative stress during fatty acid breakdown. 
Mitochondrial oxidative phosphorylation produces ROS that have to be 
neutralised. Intracellular fatty acid metabolites like diacylglycerol (DAG) can 
directly activate serine/threonine kinases that phosphorylate IRS-1 and 2 with 
the consequence of decreased PI3K activation and impaired downstream 
signalling of the insulin receptor (Randle et al., 1963; Sesti, 2006; Boucher et 
al., 2014).  
Moreover, high energy intake implies an increased production of ROS 
leading to activation of various cellular stress-response pathways, which can 
interfere with the physiological cellular signalling pathways (Bloch-Damti & 
Bashan, 2005). If fatty acids accumulate to a large extent, anti-oxidative 
molecules and pathways cannot be regenerated in time, which leads to 
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accumulation of ROS that emerge when excessive NADH, an electron donor in 
Acetyl-CoA- synthesis from glucose or fat, cannot be regenerated and single 
electrons are transferred to oxygen (Maechler et al., 1999). The development of 
insulin resistance might thus represent a compensatory mechanism protecting 
the cell against further insulin-stimulated energy substrate uptake in an attempt 
to reduce oxidative stress (Ceriello & Motz, 2004). Increased circulating ROS 
have further detrimental effects leading to inflammatory responses, 
mitochondrial dysfunction, and insulin resistance (Figure 2). 
In humans, decreased insulin sensitivity that finally leads to insulin resistance 
can often be diagnosed in overweight or obese persons (DeFronzo & Ferrannini, 
1991). Here, long-term overexposure to insulin due to excess energy intake 
(hyperinsulinemia) is detrimental for the functioning of physiological insulin 
signalling and can, as a consequence, lead to the manifestation of type 2 diabetes 
with chronic hyperinsulinemia but a lack of response to insulin in the target cells 
(Kahn et al., 2006). 
In the dairy cow, insulin signalling is different from humans in some aspects 
due to changes in insulin sensitivity linked to the lactation period. During late 
pregnancy and continuing postpartum, the cow develops insulin resistance in 
adipose tissue and muscle (Bell, 1995). This is explained by the excessive energy 
requirements during early lactation where most glucose goes to the mammary 
gland where glucose uptake is mostly regulated through GLUT1, and this form 
of glucose transport is insulin independent (Komatsu et al., 2005, Rose et al., 
1997). 
In contrast to insulin resistance in over-conditioned cows or during obesity – 
where hyperinsulinemic conditions appear – circulating insulin and glucose 
concentrations are low after parturition (De Koster & Opsomer, 2012).  
This adverse condition where hypoinsulinemia and insulin resistance appear 
simultaneously highlights the complexity of different mechanisms involved in 
insulin signalling and its pathophysiological mechanisms. The beneficial or 
detrimental effect of elevated insulin concentrations always needs to be put in 
the context of the nutritional situation, and this explains why both high and low 
insulin levels can imply stress for the individual.  
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Figure 3. Insulin signalling during insulin resistance.  
Akt/PKB = Protein kinase B, ER = Endoplasmic reticulum, GRB2 = Growth factor receptor-bound protein 2, 
IRS = Insulin receptor substrate, MAPK = Mitogen-activated protein kinase, MEK = Mitogen-activated protein 
kinase kinase, NEFA = Non-esterified fatty acids, P = Tyrosine phosphorylated state, PI3K = 
Phosphatidylinositol-4,5-bisphosphate 3-kinase, PIP2 = Phosphatidylinositol 4,5-bisphosphate, PIP3 = 
Phosphatidylinositol (3,4,5)-trisphosphate, Raf = Rapidly accelerated fibrosarcoma, Ras = Ras protein, ROS = 
Reactive oxygen species, SH2 = Src homology 2 domain-containing, Shc = Shc protein, SoS = son of sevenless, 
*activated 
1.2.5 Insulin and insulin-like growth factors 
Insulin-like growth factors (IGFs) are mitogen polypeptides, so-called survival 
factors that have structural similarities and functional interactions with insulin 
and insulin signalling pathways. Both IGF-1 and 2 have important roles both in 
pre- and postnatal growth (DeChiara et al., 1991; Baker et al., 1993). IGF-1 is 
expressed at low levels in the embryo and thus is seen as more important for 
postnatal development and growth control than during the embryonic and foetal 
period. However, mice nulliparous for IGF-1 have been shown to have more 
than 60% decreased birth weight compared to wild type mice (Powell-Braxton 
et al., 1993). 
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IGF-2 is maternally imprinted and is mainly involved in prenatal growth 
through IGF-1 and insulin receptor. This shows that the insulin receptor, besides 
its important role in insulin signalling by transmitting metabolic effects, acts on 
growth control during embryogenesis (Louvi et al., 1997). 
In the bovine, transcripts of IGF-1 and 2 and receptors for insulin, IGF-1, and 
IGF-2 are detectable during the entire preimplantation period, highlighting their 
importance for growth control. Because all of these growth factors can bind to 
all the different receptor types (see Figure 8), the different actions are dose and 
time dependent.  
1.2.6 Insulin and fertility 
Insulin is an important hormone in the regulation of fertility. The interaction of 
insulin with other reproductive hormones is necessary because insulin serves as 
a sensor for metabolic balance, and a certain minimum energy supply needs to 
be available for reproductive functions such as ovulation (Hill et al., 2008). This 
is evolutionarily explainable because energy supply must reflect the 
requirements needed throughout the pregnancy. 
Insulin plays a central role in reproduction through direct signalling in the 
brain. It connects the regulation of the energy status to reproductive functions in 
the ovary (Bruning et al., 2000). This happens through the hypothalamus–
pituitary–ovarian axis where insulin can influence the gonadotropin-releasing 
hormone (GnRH) release pattern from hypothalamic neurons in the brain 
(Sánchez et al., 2012). This interaction is mediated together with growth 
hormone and IGF. If circulating IGF and insulin levels are low due to maternal 
malnutrition or undernutrition, basal GnRH secretion is suppressed and/or its 
pulsatile secretion is depressed (Butler et al., 2003), and this can delay important 
reproductive events, including the onset of puberty, and can impact on 
reoccurring events such as ovulation (Garcia-Garcia, 2012). 
Importantly, both high-energy conditions as well as undernutrition can have 
detrimental effects on fertility. Because the ovarian pool is fixed at birth, all 
oocytes will go through possible periods of metabolic imbalance and possible 
negative impacts might be retained. This is why the consequences of metabolic 
stress on fertility might last longer than the stress situation itself. The 
consequences of cumulus-oocyte complex (COC) or embryo exposure to insulin 
vary depending on the targeted period of life and the metabolic status of the 
mother, and this has been shown by several authors. In the study of Armstrong 
(Armstrong et al., 2001), a diet leading to higher peripheral insulin 
concentrations was beneficial for the growth of the dominant follicle but 
impaired oocyte quality. Also, high circulating insulin levels have been shown 
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to be beneficial for the resumption of cyclicity after parturition (Gong et al., 
2002) while this was not valid for heifers with already elevated body weight. A 
feed regimen designed to lower body weight gain was shown to lead to better 
embryo yield and quality after collection when compared to heifers with high 
body weight gain (Freret et al., 2006). Moreover, oocyte quality was reduced in 
hyperinsulinemic heifers (Adamiak et al., 2005a), and chronic dietary restriction 
resulted in a reduction in dominant follicle growth rate, diameter, and 
persistence, and the animals became anoestral (Diskin et al., 2003). These 
studies highlight the importance of a feeding strategy taking into account the 
energy requirements for follicular growth without compromising oocyte quality 
and conception rates (Garnsworthy et al., 2009). 
In the ovary, insulin is distributed through the ovarian blood flow and reaches 
the follicular fluid and thus comes into direct contact with the oocyte via 
transudation (Poretsky et al., 1999). Insulin receptors are present in all ovarian 
compartments, such as granulosa and theca cells, as well as in the stroma and on 
the oocyte (Poretsky et al., 1985), and this shows the importance of insulin 
signalling on the different ovarian cells. In humans, insulin concentrations in the 
follicular fluid are positively related to progesterone levels (Diamond et al., 
1985) and insulin is thus, as in other mammals, presumed to be involved in 
oocyte maturation (Totey et al., 1995). In cattle, insulin concentrations in the 
follicular fluid are dependent on follicular stage, and insulin tends to be higher 
in preovulatory compared to subordinate follicles. However, the basal level of 
circulating insulin is influenced by diet, independently of follicle stage (Landau 
et al., 2000).  
Besides a direct role of insulin in follicular development, it can have 
gonadotropic functions and stimulate steroidogenesis, and the gonadotropic 
effect of insulin becomes evident in ovarian hypofunction that can be observed 
in women with type 1 diabetes (Poretsky & Kalin, 1987). Insulin can potentiate 
the response of ovarian cells to gonadotropins on three levels: 1) through 
increased LH binding capacity on granulosa cells (Adashi et al., 1985), 2) by 
sensitizing the pituitary gland to GnRH (Soldani et al., 1994), and 3) by 
influencing the GnRH secretion of the hypothalamus (Sánchez et al., 2012). 
In particular, it is well studied how insulin stimulates steroidogenesis both in 
vivo and in vitro. Most of the functions of insulin on the ovary are closely linked 
to the IGF system, including the locally produced IGF binding-proteins (Spicer 
& Echternkamp, 1995). Hyperandrogenism in the insulin-resistant state is 
probably partly transmitted through the IGF receptor that binds insulin if insulin 
is applied in supra-physiological doses (Poretsky, 1991; Monget & Bondy, 
2000). Thus, diet-induced hyperinsulinemia could lead to dysregulation of 
insulin’s physiological ovarian functions as a mitogen and its effects on the 
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stimulation of progesterone production in granulosa cells, androgen production 
in theca cells and progesterone production in luteal cells. (Spicer & 
Echternkamp, 1995). 
The role of insulin in the final stage of oocyte maturation is based on several 
facts. Insulin signalling is dependent on the responsiveness of the target tissue 
through increased expression of insulin receptors. In the preovulatory follicle, 
insulin receptors are upregulated, and this is associated with increased estradiol 
production, which supports insulin’s action in final maturation and ovulation. 
The increased expression of receptors in the preovulatory period could thus be a 
crucial factor in transitioning the follicular development to the preovulatory 
stage (Gong et al., 1991; Shimizu et al., 2008). In humans, insulin acts as a local 
factor through the insulin receptor, initially appearing in granulosa cells of the 
preantral follicle (Samoto et al., 1993). 
Circulating insulin levels vary during the oestrous cycle with a peak on the 
day of ovulation, and feeding a diet that leads to hyperinsulinemia significantly 
reduces the steady-state distribution of insulin receptors in healthy follicles 
(Armstrong et al., 2001).  
1.2.7 Insulin and in vitro embryo production 
Insulin signalling components are expressed in cumulus cells (CCs) and oocytes 
(Acevedo et al., 2007), and insulin signalling is highly important in the very first 
stages of embryonic development. Transcripts for the insulin and IGF-1 and 2 
receptors are detectable at all stages of cattle embryo development from zygote 
to the blastocyst, which shows the potential of insulin to act at all of these stages 
(Schultz et al., 1992). 
Known for its mitogenic effect, insulin has been used for many years as a 
stimulatory factor in in vitro cell culture systems and thus also for in vitro 
embryo production (IVP). In vitro concentrations used in the different media are 
often much higher (1 to 10 mg/ml) compared with those found physiologically 
in follicular fluid (0.1 to 1 ng/ml) (Laskowski et al., 2016b), and this is due to 
the different stabilities of insulin in vitro and in vivo (Hayashi et al., 1978). The 
reported effects of insulin on early embryonic development vary in the different 
in vitro studies, and often no effects on the blastocyst rate have been observed 
(Zhang et al., 1991; Shamsuddin et al., 1993; Bowles & Lishman, 1998; Fouladi-
Nashta & Campbell, 2006). Possible positive mechanisms of insulin during 
embryonic development include anti-apoptotic and mitogenic functions (Byrne 
et al., 2002). However, elevated insulin might increase oxidative stress through 
its metabolic function in the cells and thus lower embryo survival, and several 
reported changes in phenotype or gene expression due to insulin-dependent 
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signalling illustrates the potential role of insulin acting at several different levels 
during final oocyte maturation and early embryo development. 
1.2.8 Comparative aspects 
Situations with elevated or decreased levels of circulating insulin exist in both 
cattle and humans and in both species, the important role of insulin signalling 
for maintenance of reproductive functions and the link between metabolism and 
fertility has been described (Schneider, 2004). 
The NEB of the dairy cow postpartum is a well-known example where energy 
deficiency leads to a failure to maintain reproductive functions and shows the 
important role of insulin in governing fertility functions (Wathes et al., 2003; 
Pryce et al., 2004; Butler, 2005). The consequences of decreased circulating 
insulin levels for fertility are late resumption of cyclicity postpartum and delayed 
ovulation, both of which are poor conditions for early embryonic development 
and for the maintenance of the pregnancy. This effect is mainly transmitted 
through the role of insulin in the brain, where GnRH and LH pulse frequency is 
reduced if insulin levels are low, leading to decreased oestrogen production. The 
same is observed in humans with severe chronic energy deficiency, such as in 
anorectic women who develop amenorrhea (De Souza & Metzger, 1991) and 
who have reduced fertility outcomes for both natural conception and assisted 
reproductive technologies (ART) (Veleva et al., 2008). Furthermore, it is well 
known that both obesity in women and overfeeding in cows are detrimental for 
fertility. Hyperinsulinemia is associated with impaired oocyte quality in over-
conditioned cows (Adamiak et al., 2005b) just as women suffering from 
metabolic syndrome or type 2 diabetes have decreased oocyte quality (Niu et al., 
2014) and impaired reproductive functions (Sakumoto et al., 2010; Pantasri & 
Norman, 2014). 
The similarities between the human and bovine species provide an excellent 
opportunity to elucidate the actions of insulin, and new insights into the relation 
between metabolic and reproductive disorders could help to improve fertility in 
both species. Because experiments based on human embryos are ethically 
controversial, the need for alternative methods to gain further knowledge about 
underlying mechanisms of impaired fertility due to metabolic imbalance in 
humans becomes evident. The parallels in human and cattle ovarian reserve, 
follicular dynamics, and embryo metabolism explain the suitability of the bovine 
model for human embryonic development (Ménézo & Hérubel, 2002; Campbell 
et al., 2003a). 
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1.3 Early embryonic development 
1.3.1 Oocyte maturation 
Follicular growth until final oocyte maturation takes around three months in the 
cow in vivo (Lussier et al., 1987; Beam & Butler, 1999), with the final 
maturation occurring inside the follicle after the release of a preovulatory LH 
peak (Hyttel et al., 1999). This can be simulated for embryo production by a 
maturation period of 22–24 h in in vitro systems (Ward et al., 2002). Oocyte 
maturation is the first fundamental step in the development of a healthy offspring 
and is a complexly and highly regulated process where the interaction of the 
oocyte and its surrounding CCs prepares the oocyte on the cellular and molecular 
level for successful fertilization (Richards, 2005). The COC is an interacting 
tissue environment where the surrounding CCs support the oocyte during growth 
and final maturation by supplying it with metabolites. Pyruvate derived from CC 
glucose metabolism is the preferred substrate to provide the oocyte with energy 
(Sutton-McDowall et al., 2010, see also a more complete review in chapter 
1.3.4.). 
The cells of the COC are connected via gap junctions and communicate 
through paracrine signalling, and the oocyte is dependent on the surrounding 
cells for the completion of meiotic maturation (Matzuk et al., 2002; Hyttel et 
al.). The oocyte maturation period is known to be especially sensitive for 
stressors such as metabolic imbalance, temperature changes, and toxic 
influences (Moor & Crosby, 1985; Combelles et al., 2009). The early events in 
life are easily disturbed by such disrupters and the so-called metabolic 
programming occurs peri-conceptionally (Fowden et al., 2006; Martin-Gronert 
& Ozanne, 2012) with potential negative effects for the offspring lasting 
throughout its life and possibly even transmitted to subsequent generations.  
In vivo, COCs are exposed to the follicular fluid, the composition of which is 
closely correlated to the situation in the maternal serum (Spicer & Echternkamp, 
1995; Landau et al., 2000). This fact explains the strong link between nutrition, 
metabolism, and oocyte quality because metabolites and hormones in the 
circulation will also come in direct contact with the oocyte (Landau et al., 2000; 
Leroy et al., 2012). The maternal nutritional state can programme the oocyte’s 
metabolism at this early stage of development (O’Callaghan & Boland, 1999; 
Fleming et al., 2012). 
For final maturation and thus being prepared for successful fertilization, the 
oocyte has to go through several nuclear and cytoplasmic changes (Hyttel et al., 
1986; Eppig, 1996; Fulka et al., 1998). 
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Briefly, cytoplasmic maturation involves a range of metabolic and structural 
changes, allowing subsequent fertilization, cell cycle progression from meiosis 
to mitosis, and activation of several pathways for the programming of 
preimplantation development (Eppig et al., 1994; Trounson et al., 2001). 
From having mitochondria distributed in a peripheral pattern, the LH peak 
induces the formation of mitochondria clusters associated with lipid droplets. At 
the same time, the formation of the perivitelline space with loss of contact 
between CCs appears (Kruip et al., 1983).  
On the nuclear level, the nuclear envelope ruffles and meiosis resumes, 
visible by germinal-vesicle breakdown. In the final stage, the polar body is 
extruded, the mitochondria disperse, and most organelles move to the centre of 
the oocyte while cortical granules are formed in the periphery (Kruip et al., 1983; 
Combelles et al., 2002). 
1.3.2 Development until the blastocyst stage 
The fertilized oocyte is called a zygote and contains all of the materials for 
initiating the first developmental steps, including new protein synthesis, mRNA 
activation, protein and RNA degradation, and reorganization of the organelles in 
the cell (Stitzel & Seydoux, 2007). The first cleavage occurs 25–26 h post 
fertilization (Hamilton & Laing, 1946; Sakkas, 2001). The first cell divisions are 
under maternal control and are based on stored mRNA and protein molecules in 
the oocyte before the embryonic genome takes over transcription (Barnes & 
Eyestone, 1990) (see more in section 1.3.1). At 42–44 h post fertilization, the 
embryo should have reached the 4- to 8-cell stage with equal numbers of 
blastomeres (Betteridge & Fléchon, 1988). Early cleavage dynamics have been 
reported to be a tool to predict embryo quality and developmental potential (Van 
Soom et al., 1992; Kubisch et al., 1998; Lonergan et al., 1999), and the fastest-
growing embryos seem to have the best viability and potential to reach the 
morula and blastocyst stages. 
The next ultrastructural change is morula formation at the 32-cell stage when 
compaction occurs (Van Soom et al., 1992). The blastomeres become either part 
of the embryonic inner cell mass (ICM) or the trophoblast that will form the 
foetal annexes (Betteridge & Fléchon, 1988). In the bovine, the transition from 
compacted morula to the blastocyst stage occurs between day 6 and 8 of 
development (Betteridge & Fléchon, 1988). The most important characteristic 
of a blastocyst is the formation of the blastocoel cavity and the clearly 
distinguishable ICM. The embryo is enclosed by the zona pellucida until 
hatching (Lindner & Wright, 1983).  
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1.3.3 Embryo morphology 
The most accurate evidence for the developmental competence of an embryo is 
to allow development into a live, healthy offspring. This is, for several reasons, 
not always applicable for research purposes. Thus, other methods have been 
established with the aim of predicting oocyte developmental potential and 
embryo quality (Van Soom et al., 2003).  
Basic developmental data at different time points are usually recorded to 
follow the different developmental steps and to look for signs that the embryo 
might fail to pass the important thresholds such as first cleavage, embryonic 
genome activation (EGA), compaction, and blastocyst formation (Andra et al., 
1999; Lonergan et al., 2006). On Day 7 and 8, morphological evaluation of 
blastocyst stages and quality grading of blastocysts is possible at a more 
advanced level and includes several criteria. The diameter of a Day-8-blastocyst 
(BC8) is approximately 150 to 190 m, including a zona pellucida thickness of 
12 to 15 m, and some parameters that are included in the evaluation of embryo 
quality are shape, colour, cell number, presence of extruded and degenerated 
cells and size of the perivitelline space (Lindner & Wright, 1983, Crosier et al., 
2001). In addition to these, staining for the actin skeleton, mitochondrial pattern 
(Zijlstra et al., 2008), lipid droplets (Abe et al., 1999, 2002), and apoptosis (Yang 
et al., 1998; Gjørret et al., 2003) can be used to detect differences in embryo 
phenotype and allows, together with the developmental rates, conclusions to be 
drawn about the embryo's viability. 
The first important assessment criterion is light microscopy determination of 
the developmental stage (Shea, 1981) to ensure that the embryo is not retarded 
in development compared to the other embryos of the same day of development. 
On Day 8, the blastocyst can be early, blastocyst, expanding, expanded, 
hatching, or hatched and the different blastocyst stages were described and 
defined by Lindner and Wright in 1983 (Lindner & Wright, 1983), and the same 
staging criteria are still used today. In brief, an early blastocyst has already 
formed a fluid-filled blastocoel and the embryo itself forms around 70 -80% of 
the volume. The blastocyst stage is characterised by a growing blastocoel that is 
highly prominent, and compaction of the embryo (differentiation between ICM 
(darker) and trophoblast) becomes visible. Up to this stage, the diameter of the 
embryo does not change much from the size of the oocyte. When the embryo is 
expanding or expanded, the zona pellucida thins and the embryo diameter 
increases. The next stage is the partly hatched (hatching) or entirely hatched 
embryo, at which point it has shed the zona pellucida. All of these stages can be 
found on Day 8 of development. 
The next step is to assess the embryo quality grade according to the 
guidelines that have been developed by the International Embryo Technology 
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Society (IETS) (Stringfellow DA, 2010). The quality grades are indicated by a 
descending scale between 1 and 4 where 1 stands for “excellent/good”, 2 for 
“fair”, 3 for “poor” and 4 for “dead/degenerated”. 
Following different types of staining, more characteristics can be evaluated 
such as cell number, mitochondria distribution, and actin cytoskeleton structure. 
A blastocyst on Day 8 contains around 100–200 cells (Byrne et al., 1999; 
Watson et al., 2000), and larger embryos are often assessed as more viable 
because they are further advanced in their development. However, there are also 
other theories that claim that moderate growth is beneficial for the long-term 
viability of the embryo and health of the offspring (Leese et al., 2008). 
Mitochondria are the energy providing organelles in cells and are reported to 
have important functions in competent oocytes and blastocysts (Lane & Gardner, 
1998; Bavister & Squirrell, 2000). The mitochondrial activity and pattern in the 
embryo varies depending on developmental stage (Tarazona et al., 2006). 
However, an even distribution between all blastomeres with no accumulations 
or empty areas within the blastocyst is considered to be beneficial for the 
viability of the embryo (Båge et al., 2003; González & Sjunnesson, 2013). The 
same is true for actin distribution in all parts of the embryos where good quality 
embryos often show an equal distribution pattern, while degraded or low quality 
embryos show cytoskeleton disintegration and might thus be more fragile and 
less viable (Zijlstra et al., 2008; González & Sjunnesson, 2013). 
1.3.4 Oocyte and embryo metabolism 
Oocyte maturation and the first developmental steps such as growth, cell 
division, and differentiation are energy-consuming processes that require a high 
availability of energy substrates (Gardner, 1998). The embryo itself or through 
the CCs is able to metabolize different types of substrates such as glucose, 
triacylglycerides, and amino acids. Besides these exogenous substrates that are 
present in oviductal fluid or in vitro media, endogenously stored 
triacylglycerides and glycogen are reported to contribute to energy availability 
during early development (Brinster, 1971; Ferguson & Leese, 2006). Before 
elongation, embryos are reliant on oxidative phosphorylation of pyruvate, 
lactate, and amino acids for ATP production, with increasing glucose 
consumption in more advanced stages after compaction (Leese, 1995; 
Thompson et al., 1996; Thompson, 2000). Besides providing energy, 
carbohydrate and amino acid metabolism generates substrates with functions in 
the cellular stress response (Gardner, 1998).  
Oocyte metabolism is tightly connected to CC metabolism (Figure 4), and in 
the early stages of development the CCs provide the oocyte with pyruvate, its 
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most favourable substrate (Sutton-McDowall et al., 2010). Oocyte-CC 
communication continues even after meiotic resumption when most of the gap 
junctions are lost (Sutton et al., 2003). Oxygen consumption is a good measure 
of metabolic activity, and during maturation it is at similar levels as at the 
blastocyst stage (Houghton & Leese, 2004) and the total ATP content is 
increased in mature oocytes (Stojkovic et al., 2001; Ferguson & Leese, 2006). It 
has been shown that LH increases glycolysis in bovine oocytes, and this is 
assumed to be the mechanism through which LH enhances maturation (Zuelke 
& Brackett, 1992). 
Glucose consumption has been used to predict embryos with high 
developmental potential in mice (Gardner & Leese, 1987) and cattle (Renard et 
al., 1980). However, moderate glycolytic activity close to levels that are found 
in vivo seems to be best for viability of the embryo (Lane and Gardner, 1996). 
Here, elevated insulin levels could contribute to excess glucose consumption 
during early embryo development and thus have an adverse effect on viability. 
Glucose metabolized through the pentose phosphate pathway generates ribose 
that can be used for nucleic acid production and NADPH for glutathione 
regeneration through reduction, an important pathway against ROS (Wales, 
1973; Rieger, 1992; Gardner, 1998). 
Lipid metabolism also varies depending on development stage and can be of 
exogenous or endogenous sources (Ferguson & Leese, 2006; Haggarty et al., 
2006). In humans, it has been shown that pre-implantation embryos actively take 
up fatty acids (Haggarty et al., 2006). Besides triacylglycerides and fatty acids, 
even cholesterol has important functions during embryogenesis, and impaired 
cholesterol metabolism might have detrimental consequences for the embryo 
(Farese & Herz, 1998). 
Amino acids are possibly consumed to a different extent depending on 
embryo developmental stage (Partridge & Leese, 1996; Lane & Gardner, 1998). 
Alanine and glutamine are precursors for gluconeogenesis (Felig et al., 1970), 
but their contribution to energy supply is limited. Other functions of amino acids 
might be of higher relevance during embryo development because they function 
as substrates for biologically important molecules such as melanin (Korner & 
Pawelek, 1982), as osmolytes, as buffers, and as regulators of embryo 
metabolism (reviewed by Gardner, 1998), and this explains their role in embryo 
development (Takahashi & First, 1992). 
In summary, any dysregulation in substrate availability or metabolic 
functions might lead to disturbances in healthy embryo development. This 
highlights the importance of developing adequate media for IVP of embryos that 
is similar to the conditions found in vivo because requirements for the different 
metabolites could change during development, and it also explains why 
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metabolic disturbances in the mother might lead to conditions that are 
suboptimal for embryo viability. 
 
 
Figure 4. Proposed model of the metabolic interactions and activity of CCs and the oocyte. 
Numerous energy substrates are supplied to the COC by the surrounding fluid, including glucose, 
pyruvate, lactate, and amino acids.  
Glucose can be utilized via three major pathways: (i) glucose oxidation (the combination of glycolysis, 
tricarboxylic acid (TCA) cycle and oxidative phosphorylation); (ii) the pentose phosphate pathway (PPP); or (iii) 
it can be converted to intermediates and utilized for extracellular matrix (ECM) expansion. FSH stimulates 
glucose metabolism by cumulus cells. Glucose utilization begins with glycolysis (within cumulus cells) where 
glucose-6-phosphate is converted to pyruvate, which can then enter the oocyte directly or be converted to lactate. 
Pyruvate is further oxidized by the TCA cycle within ovum mitochondria, followed by oxidative phosphorylation 
in the mitochondrial intermembrane where ATP is released by electron transfer. PPP also begins with the 
oxidation of glucose to glucose-6-phosphate within cumulus cells, with one of the products of the pathway, 
phosphoribosyl pyrophosphate (PRPP), being used by the oocyte for purine synthesis. Purines are involved in 
the regulation of nuclear maturation. PPP is also involved in general cytoplasmic homeostasis since NADP+ is 
reduced to NADPH. Amino acids cystine and cysteine are involved in the production of glutathione (GSH), 
accumulation of which appears essential for early embryonic development. Although oocyte-secreted factors are 
known to have major effects on development and differentiation of cumulus cells, there are no data available 
concerning their effects on the metabolism of cumulus cells. GSSG= oxidized GSH; ROS = reactive oxygen 
species. Reprinted with permission from (Sutton et al., 2003). 
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1.3.5 In vitro produced embryos 
Compared to their in vivo counterparts, IVP embryos are in general less viable. 
Blastocyst development rates are lower in vitro, and differences in morphology, 
metabolism, gene expression, epigenetics, cryotolerance and pregnancy rates 
after transfer have been studied in order to explain their decreased 
developmental competence (Wright & Ellington, 1995; Thompson, 1997). 
One explanation for these differences is an increased exposure to oxidative 
stress during in vitro culture (Cagnone & Sirard, 2013; de Assis et al., 2015).  
Many attempts to improve culture conditions and protocols have been made in 
recent decades resulting in improved IVP, but differences in embryo quality are 
still observed (Niemann & Wrenzycki, 2000; Galli et al., 2003; Hasler, 2003). 
For example, Khurana and Niemann (2000b) detected differences in aerobic 
glycolysis rate and lactate oxidation between IVP and in vivo embryos. 
Some authors observed differences in morphology in the form of a darker 
overall appearance with larger blastomeres at early stages and a reduced 
perivitelline space along with reduced viability of IVP, with fewer IVP embryos 
surviving the cryopreservation procedures (Khurana & Niemann, 2000a; Rizos 
et al., 2002). Even if not having a consistently different morphology, a mismatch 
in timing might exist in IVP embryos that leads to delays in development (Plante 
& King, 1994).  
In vitro, typical developmental rates for bovine embryos are 20–40% 
(Thompson & Duganzich, 1996; Rizos et al., 2002), and gene expression studies 
have been used with the aim of discovering the underlying reasons for the 
impaired developmental potential of IVP embryos. Important genes for 
development are differentially expressed in IVP embryos, e.g. connexion 43, 
which plays a role in maintaining compaction (Wrenzycki et al., 1996; Niemann 
& Wrenzycki, 2000). Also, CCs have a different gene expression pattern 
depending on whether oocyte maturation occurs in vitro or in vivo (Tesfaye et 
al., 2009; Gad et al., 2012)  
Current research efforts into gene expression and regulation aim to better 
understand the epigenetic mechanisms that present a link between the genome 
and the environment and induce permanent changes in gene expression pattern 
through metabolic programming (Santos et al., 2003) (see chapter 1.4.2.) 
1.3.6  Comparative aspects between human and bovine embryo 
development  
The use of animal models to better understand mammalian embryogenesis is 
important because such models allow the study of pathophysiological 
mechanisms in the oocyte and early embryo without evoking ethical 
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controversies (Leese et al., 1998). Many morphological, metabolic, and gene 
expression studies require techniques that do not allow the embryo to survive. 
Still, more knowledge is necessary to improve culture conditions and techniques 
in both human and bovine IVP (Hasler et al., 1995; Vayena et al., 2002). 
There are similarities between cattle and humans in terms of ovarian reserve,  
follicular dynamics, and embryonic metabolism (Ménézo & Hérubel, 2002; 
Campbell et al., 2003b) that explain the suitability of the bovine model for 
human embryonic development. The bovine also has other features as major 
embryonic genome activation that are more closely related between human and 
cattle than between human and mice (Telford et al., 1990; Ménézo et al., 2000; 
Neuber & Powers, 2000). In addition, the durations of pregnancy are very similar 
between humans and cows. 
However, some differences exist in human and bovine IVP, for example the 
day of transfer is usually on Day 7 or 8 in the bovine (Hasler et al., 1995) and 
on Day 3 or 5 in the human (Coskun et al., 2000). The reason for this is to avoid 
the human embryo being outside the natural environment longer than necessary. 
Moreover, the routines for cryopreservation are different, and most of the human 
embryos are frozen before transfer because the embryo usually has to be 
transferred back into the same mother from which the oocyte was derived 
(Wallach & Trounson, 1986; Mandelbaum et al., 1998). In addition to that, the 
cryopreservation of embryos allows for the collection of multiple oocytes in only 
one ovum pick up session and allows those that cannot be used in the first fresh 
cycle to be saved for later IVP trials. In the cow, IVP embryos are often 
transferred fresh because the pregnancy results are often better than if using 
frozen embryos, and the availability of recipients is often not an issue. However, 
efforts to improve and develop freezing protocols and vitrification of livestock 
animal embryos have been made, and pregnancy rates after freezing have 
improved in the bovine species (Niemann, 1991). The combination of IVP and 
cryopreservation allows the application of new tools such as sexing or genomic 
selection in dairy cattle breeding programmes because embryos can be biopsied, 
genotyped, and transferred if the genetic value is high (Chrenek et al., 2001). 
1.4 Gene expression in early embryos 
1.4.1 Transcriptome 
The transcriptome results from the active part of the genome and consists all 
RNAs, including messenger RNA (mRNA) molecules present at a given time 
point in a specific tissue (Wang et al., 2009; Schwanhausser et al., 2011). 
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Because differential mRNA expression reflects the response to intrinsic factors 
and external influences, transcriptome analysis allows conclusions to be drawn 
about activated pathways, possible stress mechanisms, and molecular events in 
tissues, oocytes, and embryos (Katz-Jaffe et al., 2009; Ramsköld et al., 2009; 
Robert et al., 2011; Sirard, 2012). 
During early embryonic development, transcriptome analysis reveals 
interesting insights into the ongoing developmental steps and possible harmful 
impacts because certain pathways are characteristic for stress conditions (Leese 
et al., 2008; Gad et al., 2012). The transcriptome of the embryo is different from 
other cells because maternal factors dominate the initiation of the first 
developmental events, and thus the importance of oocyte quality for further 
development becomes evident (Brevini Gandolfi & Gandolfi, 2001; Sirard et al., 
2006). After a short period of common gene expression from both the maternal 
side and the embryonic genome, maternal products degrade and the embryonic 
genome takes over transcription (Telford et al., 1990). Embryonic genome 
activation (EGA) coincides with the first differentiation steps and the expression 
of genes important for implantation (Misirlioglu et al., 2006). Before EGA, 
embryonic cells are totipotent until the 4-cell stage (Van de Velde et al., 2008) 
and are pluripotent until at least the 8-cell or the 16-cell stages (Mitalipova et 
al., 2001). 
EGA is the switch from the maternal, oocyte stored mRNA-translation to 
embryonic transcriptional activation. Before that, the embryonic genome is 
transcriptionally silent and the cell divisions are under maternal control (Frei et 
al., 1989; Kopeþný et al., 1989; Vallée et al., 2009), and inhibition of the EGA 
step blocks further development (Plante et al., 1994). The timing of EGA differs 
in different species (Watson et al., 1993), and in the bovine, major EGA occurs 
at the 8–16 cell stage. However, a minor EGA of some genes related to RNA 
processing is already observed at earlier stages, probably preparing the embryo 
for major EGA and the subsequent transcription of functional genes (Memili et 
al., 1998; KaĖka et al., 2009; Graf et al., 2014). These early developmental 
stages require several activation steps and are very sensitive to disturbances that 
can lead to unknown consequences for later developmental potential. Kues et al. 
(2008) showed significant differences in gene expression pattern between in vivo 
and in vitro-derived embryos that might explain possible differences in 
developmental potential. The aim of transcriptome studies is to detect possible 
markers for survival or detrimental events in blastocysts and thus to predict their 
potential to survive the critical period of preimplantation development and to 
subsequently be able to implant and develop into a healthy offspring (Ko, 2004). 
A better understanding of early events at the molecular level could improve the 
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outcome of ART by allowing the selection of optimal embryos for transfer at an 
early stage (Niemann & Wrenzycki, 2000; Kues et al., 2008). 
1.4.2 Metabolic programming and epigenetics 
There is a growing body of evidence showing that influences early in life and 
especially around the time of fertilization can have a lasting impact on the 
offspring´s health with long-term and even trans-generational consequences 
(Calle et al., 2012). These so-called “epigenetic effects” are influenced by 
environmental factors such as toxins or the nutritional and metabolic state of the 
mother and can affect gene expression in a permanent manner. The blastocyst is 
a difficult target for methylation analysis because DNA methylation is 
progressively reduced during the pre-implantation development and because of 
high variations in stage-dependent methylation patterns (Santos & Dean, 2006). 
There are several epigenetic mechanisms involved in transmitting these 
effects, such as cytosine-methylation at CpG dinucleotides and histone 
modifications, both of which can be heritable (Godfrey et al., 2007). CpG 
methylation is a reversible and dynamic epigenetic mechanism controlling 
chromatin structure and is involved in regulating short-term and long-term gene 
expression. In particular, several de-methylation and re-methylation processes 
during early development have been defined (Chen & Riggs, 2011). While 
methylation of the oocyte genome is maximal at the germinal vesicle stage 
(O’Doherty et al., 2012), demethylation occurs in the zygote and during early 
cleavage. With major embryonic genome activation, methylation increases again 
and remains until the blastocyst stage (Dobbs et al., 2013). This plasticity of the 
methylation pattern makes the sensitivity of oocytes and early embryos for 
epigenetic reprogramming evident (Hackett & Surani, 2012; Marcho et al., 
2015). Epigenetic or metabolic programming, potentially leading to alterations 
in the epigenome of the embryo, occurs through maternal metabolic signals 
(Portha et al., 2014) 
A different DNA methylation pattern leading to changes in chromatin 
structure at regions controlling transcription of genes can result in different 
transcriptional activity of these genes and these effects can persist through the 
entire life of an offspring. Epigenetic dysregulation has been reported to cause 
metabolic disorders and obesity later in life (Li et al., 2010; Jaeger et al., 2016), 
and insulin resistance might already be present in oocytes (Turner & Robker, 
2015). There is evidence that in vitro conditions lead to perturbations in DNA 
methylation pattern (Chason et al., 2011) that can either be in the form of global 
hypomethylation (Grace & Sinclair, 2009) or hypermethylation (Deshmukh et 
al., 2011) compared to the in vivo situation. 
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Efforts to improve in vitro culture conditions should pay special attention to 
this “inheritable” factor of metabolic imbalance that impairs developmental 
competence and could have long-term consequences on the health of the 
offspring and subsequent generations (Shi & Haaf, 2002).  
 
 
 
  
45 
 
The overall aim of the thesis was to identify the effects of insulin during oocyte 
maturation on the developmental potential of bovine blastocysts. The specific 
objectives were: 
 
¾ To establish an in vitro model for elevated insulin conditions during 
oocyte maturation by using two different doses and to relate results from 
the model to in vivo situations (Paper I). 
 
¾ To investigate the effect on cleavage, developmental rates, embryo stage, 
and quality grade and to further define morphological changes in cell 
count, mitochondrial pattern, and actin structure (Paper II, III). 
 
¾ To investigate the overall effect of insulin exposure on the gene 
expression pattern (transcriptome) of Day 8 blastocysts (Paper III). 
 
¾ To further define the effects of insulin on the lipid profile of Day 8 
blastocysts by analysing gene expression related to lipid metabolism and 
lipid profile (Paper IV). 
 
 
 
 
 
 
 
 
 
 
 
 
2 Aims of the thesis  
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3.1 Experimental design 
To study the effects of insulin on developmental potential of bovine Day 8 
blastocysts, several study parts were included (Figure 5).  
In study I, the in vitro model was established by exposing oocytes during 
maturation to two concentrations of insulin – INS10 (10 g/ml) and INS0.1 (0.1 
g/ml) – and these were compared to the control group INS0 without any added 
insulin.  
In study II, the morphology of the blastocysts was investigated for 
differences between insulin-treated groups and controls. 
In studies III and IV, gene expression profiles were determined with a 
special focus on the lipid profile in study IV combined with DESI –MS analysis. 
3 Materials and methods 
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Figure 5. Experimental design and overview of studies I to IV. 
3.2 Oocyte origin and in vitro production of embryos 
For IVP, all media and constituents were obtained from Sigma-Aldrich 
(Stockholm, Sweden) if not otherwise stated. Media were freshly produced in 
the laboratory (on a daily or weekly basis depending on proven protocols) 
according to standard methods described by Gordon and modified according to 
Abraham (Gordon, 2003; Abraham et al., 2009). 
3.2.1  Oocyte collection 
As the oocyte source, ovaries were collected at a local abattoir within one hour 
post mortem and kept at 35°C until arrival at the laboratory. Follicles with 
diameters of approximately 3–8 mm, were then aspirated, and aspirates 
containing follicular fluid and oocytes were collected into TCM-199-based 
search medium. The COCs were stored in search medium for washing, 
collection, and selection. Only COCs of the best quality-grades 1 or 2 (Gordon, 
2003) were selected for maturation. The selected COCs were washed in search 
medium and randomly allocated to the INS10, INS0.1, or INS0 groups (Figure 
5).  
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3.2.2 In vitro maturation and insulin supplementation 
Before maturation, the COCs were washed in maturation medium to minimize 
the risk for contamination of the medium with search medium. 
Maturation medium consisted of bicarbonate-buffered TCM-199 (M2154) 
supplemented with 0.68ௗmM L-glutamine (G8540), 0.156 g/ml FSH and 
0.03 g/ml LH (Stimufol; PARTNAR Animal Health, Port Huron, Canada), 50 
g/ml gentamicin, and 0.4% BSA (w/v) fraction V. The COCs were matured in 
groups of 30–45 in a well containing 500 l medium supplemented either with 
no (INS0), 0.1 g/ml (INS0.1), or 10 g/ml (INS10) bovine insulin (I5500). The 
groups were incubated for 22 h (24 h after the end of aspiration) at 38.5ºC under 
an atmosphere of 5% O2, and 5% CO2. 
3.2.3 In vitro fertilization 
For the different in vitro fertilization steps, the following media were used (for 
detailed protocols see Papers II and III): washing medium, fertilization 
medium, and capacitation medium (CM). Washing medium consisted of 
modified Tyrode's albumin lactate pyruvate (mTALP), supplemented with 
0.3%ௗfraction V BSA (w/v) and 50 ȝg/ml gentamicin.  
Fertilization medium consisted of mTALP containing 0.6%ௗfatty acid-free BSA 
(w/v), 50 ȝg/ml gentamicin, 3 ȝg/ml heparin (H3149), penicillamine- 
hypotaurine-adrenaline, and sodium metabisulphite (S9000).  
Capacitation medium contained mTALP without CaCl2 and supplemented 
with 1.25 mg/ml glucose, 50 ȝg/ml gentamicin, and 0.6% BSA (w/v). 
After 22 h of maturation, COCs were transferred to four-well dishes 
containing 460 l fertilization medium. For oocyte fertilization, two sperm 
straws (250 l each) were thawed and prepared using the swim-up procedure to 
select the most motile sperm (Ng et al., 1992). The sperm suspension was added 
to the oocytes in a volume giving a final concentration of 1×10 6 spermatozoa/ml. 
Groups of 30–45 oocytes per well and spermatozoa were co-incubated at 38.5ºC 
in a maximally humidified atmosphere of 5% CO2, 5% O2, and 90% N2 for 22 
h. 
3.2.4 In vitro culture 
In vitro culture was performed in modified synthetic oviductal fluid (mSOF) that 
consisted of 0.11M sodium chloride (S5886), 7 mM potassium chloride (P5405), 
1.19 mM potassium phosphate monobasic (P5655), 25 mM sodium bicarbonate 
(S5761), 0.33 mM pyruvic acid sodium salt (P4562), 1 mM L-glutamine 
(G8540), 0.171 mM calcium chloride (C7902), 1.5 mM glucose (G6152), 110 
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mM sodium lactate (L7900), and 0.49 mM magnesium chloride (M2393), with 
the addition of minimum essential medium non-essential amino acids solution 
(100×; M7145), amino acids solution (50×; B6766), 0.4% fatty acid-free BSA 
(w/v), and 50 g/ml gentamicin. 
After the fertilization period, presumed zygotes were denuded and 
transferred into culture conditions where they were incubated until Day 8 under 
a humidified atmosphere of 5% CO2, 5%O2, and 90% N2 at a temperature of 
38.5ºC in 500 l mSOF medium covered with paraffin oil (Ovoil; Vitrolife AB, 
Gothenburg, Sweden). 
 
3.2.5 Measurement of insulin concentrations by ELISA 
Insulin concentrations in the INS0.1 and INS10 groups were analysed at three 
different time points: before maturation when the medium itself had been pre-
incubated and before any COCs were added (BM); after maturation with co-
incubation of COCs for 22 h (AM), and a control containing only medium 
incubated for 22 h without any COCs: “after maturation empty” (AME). A 
bovine insulin ELISA for quantitative determination of bovine insulin in serum 
or plasma specially optimized for bovine samples, was used (Mercodia, Nr. 10-
1201-01). No advanced statistical analysis was applied because the small study 
size did not allow for more than a numerical assessment.  
 
 
3.3 Embryo morphology 
3.3.1 Developmental rates, stage, and grade 
The proportion of cleaved embryos (“cleavage rate”) was checked 44 h after 
fertilization noting also the proportion of embryos beyond the 2-cell stage. On 
Day 7 and 8, the blastocyst rate was recorded (number of blastocysts per number 
of immature oocytes). On Day 8, blastocysts were graded for quality (grades 1 
to 4) and developmental stage (blastocyst, expanded blastocyst, hatching 
blastocyst, or hatched blastocyst) modified according to (Stringfellow DA, 2010; 
Bo & Mapletoft, 2013). Morphological evaluation is described in detail in 
chapter 3.3.3 and Paper II.  
Resulting blastocysts were removed from the culture medium for immediate 
staining and microscopy or stored frozen at í80°C for future RNA preparation 
and subsequent gene expression studies. 
51 
 
3.3.2 Embryo staining 
In total, 178 Day 8 blastocysts (BC8s) were used for morphological evaluation. 
Three different dyes were used to stain active mitochondria (Mitotracker 
Orange, Invitrogen M7510), DNA (Hoechst 33342, Sigma), and actin 
cytoskeleton (Alexa Fluor 488, A 12379, Invitrogen). 
Blastocysts were first stained with 200 nM Mitotracker Orange dissolved in 
mSOF and put overnight in fixing solution. Actin staining was performed the 
following day with Alexa Fluor 488 Phalloidin after 10 min of permeabilization 
with Triton X-100. Hoechst staining was performed with 4.45 M dye for 20 
min. Mounting in black-well plates in Vectashield (Vector Laboratories, 
Burlingame, CA, USA) was done after three washes in PBS with 0.1% polyvinyl 
alcohol (PVA) to clean the remaining dye from the embryos. Embryos were 
placed in the centre of the well and Vectashield was added around the drop until 
the well was completely filled. 
3.3.3 Morphological evaluation of embryos 
Images were taken using a confocal laser scanning microscope (LSM 510, Carl 
Zeiss AB, Jena, Germany). An epifluorescence and a fluorescence microscope 
camera were used for acquiring the images. Image analysis was performed using 
ZEN 2008 Light Edition Software (Carl Zeiss; http://www.zeiss.com). 
     Each BC8 image was captured using standard settings at 20× magnification, 
and one camera image of the epifluorescence microscope (CAM) was taken with 
focus in the central area of the blastocyst.  
Staging and grading information from the light microscopy analysis was used 
to identify and evaluate the individual BC8s. During the evaluation process, no 
information was given about the treatment group or other characteristics 
(blinded study). Twelve consecutive Z-stack planes were merged into a three-
dimensional image in order to assess actin cytoskeleton grade and mitochondria 
categories in each embryo. 
The number of nuclei was counted by two independent evaluators from the 
CAM image (blue Hoechst staining, Figure 6A) that was transformed into a 
black and white image (Figure 6B). The average of both counts was calculated 
and if the sums differed by more than 10%, the count was repeated. If the counts 
still differed by more than 10%, the counts were deleted from the final 
calculations. 
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A          B   
Figure 6 A: Staining of nuclei with Hoechst dye and cell counts in BC8 (confocal 3D image),  
and 6 B: Black and white version with arrows indicating examples for cell nuclei that have been 
counted. 
Actin cytoskeleton structure was evaluated by using three different quality 
categories, as previously described by (Zijlstra et al., 2008; González & 
Sjunnesson, 2013) where ACTIN1 was classified as most favourable and 
ACTIN3 as the lowest quality pattern. All images were evaluated twice by the 
same person in a blinded procedure. Precise information about the different 
categories is given in Table 1, and examples are given in Figure 7. Briefly, 
ACTIN1 indicated a sharp staining of cell borders and an abundant 
microfilament complement in at least 75% of all cells. ACTIN2 was given to 
embryos if gross maintenance of the cell outline was observed, but some 
clumped or scant microfilaments were present in the cytoplasm. If cell integrity 
was lost and actin filaments were visible as clumps or aggregates, embryos were 
categorized as ACTIN3. 
For classification of mitochondria staining, two categories were used to 
evaluate spatial distribution pattern of active mitochondria.  
The first category, MITO, contained three grades according to (González & 
Sjunnesson, 2013) as described in Table 1 and shown in Figure 5. In brief, 
MITO1 had an even distribution of active mitochondria in more than 90% of the 
cells and there were no outlier cells with extreme staining or large accumulations 
of dye. MITO3 embryos lacked active mitochondria in some cells or areas and 
had some overstained cells, blurry staining, large accumulations, or unclear cell 
borders. MITO2 was the intermediate class for embryos that had a few of the 
characteristics of class MITO3, but only to a small degree. 
The second mitochondria category – MitoC (“mitochondria centred”) – was 
used to further describe differences in mitochondria quality based on the spatial 
distribution of active mitochondria in the cytoplasm. MitoC1 was given to 
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embryos if there was a clear, even mitochondria distribution pattern in all 
blastomeres and a clear empty area where the cell nucleus was located. Embryos 
with a similar pattern in approximately 50–75% of cells were categorized as 
MitoC2, and all other embryos were graded as MitoC3 (Table 1 and Figure 7; 
confocal 3D image). 
 
 
 
Figure 7. Actin and mitochondria staining and categories. Examples of actin categories in F-actin 
(Alexa Fluor 488 Phalloidin) stained Day 8 blastocysts (Confocal 3D image). 
 
A1 = ACTIN1; A2 = ACTIN2 and A3 = ACTIN3 (arrows indicating 1) aggregated microfilaments and 2) lost 
cell integrity). Examples for mitochondria category in active mitochondria (MitoTracker Orange)–stained Day 
8 blastocysts: M1 = MITO1; M2 = MITO2, M3 = MITO3 (arrows indicating 3) accumulations/clusters and 4) 
“empty” areas); MC1 = MitoC1 (arrows indicating 5) clear cell borders and 6) unstained nucleus area); MC2 = 
MitoC2 (arrows indicating 7) cells with mitochondria distributed around the nucleus and 8) areas with an absence 
of cells with clear mitochondria distribution around the nucleus); MC3 = MitoC3 (arrows indicating 9) large 
areas without a distribution pattern around the nucleus and 10) areas with no clear cell borders). 
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Table 1. Summary of the morphological categories and characteristics used to asses actin and 
mitochondria (1= “best” category for all parameters). 
Parameter 
 
Abbreviation Category Definition 
Actin structure 
 
ACTIN 1 
Sharp cell borders, abundant microfilament in 
cytoplasm 
 
 
2 
Gross maintenance of cell outline, but some 
aggregated/clumped microfilaments 
 
 
3 
Aggregated clumps and loss of cell integrity 
in the main part of the embryo 
Mitochondria 
 
 
 
MITO 1 
Evenly distributed, distinctly present in 
almost all cells, distinct points of staining, no 
or few small accumulations, no extremely 
stained cells (“cluster/blobs”) 
 
 
2 
1 or 2 deviations from Mito1, but other 
factors fulfilled 
  3 More than 3 serious deviations from class 1 
Mitochondria 
location 
 
MitoC 1 
Centered around the nucleus and clear cell 
borders in all cells 
 
 
2 
Centered around the nucleus in more than 
50% of cells 
 
 
3 
No centered pattern visible, or less than 
MitoC2 
 
3.4 Microarray-based transcriptome studies of embryos 
 
Detailed protocols and PCR details are given in papers II, III, and IV. 
3.4.1 Embryo pooling and freezing 
RNAse-free conditions were used for all of the following steps to avoid 
contamination and degradation of the RNA. Each BC8 was separately put in 2 
l of PBS-PVA and frozen at í80ÛC. For RNA extraction, pools of 10 embryos 
with equally distributed developmental stages and quality grades per pool were 
generated to provide the minimum amount of RNA for the extraction method. 
Four replicates of 10 embryos per treatment (INS10, INS0.1, and INS0) were 
used for the RNA analyses (n = 120 BC8s). 
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3.4.2 DNA/RNA extraction and RNA amplification and labelling 
RNA extraction and the following steps for gene expression analysis were 
performed according to methods developed by the EmbryoGENE platform 
Canada (Robert et al., 2011, and Paper III). Total RNA and genomic DNA were 
extracted in parallel using the AllPrep DNA/RNA micro kit (Qiagen, Hilden, 
Germany), and genomic DNA was kept at í80°C for subsequent epigenetic 
studies. Total RNA was assessed for quality parameters and quantity and 
reached RNA integrity numbers above 7.5. The extracted RNA was used for 
microarray analysis and for validation using reverse transcribed quantitative 
PCR (RT-qPCR) analysis.  
RNA amplification was required because of the limited amount of RNA in 
the starting material. The RiboAmp®HS-plus RNA-amplification Kit (Life 
Technologies, ON, Canada) was used for linear amplification based on the 
Eberwine method (Van Gelder et al., 1990). The purity and concentration of the 
resulting anti-sense ribonucleic acid (aRNA) was analysed by Nanodrop (Fleige 
& Pfaffl, 2006). All 12 samples fulfilled the quality criteria. Validation of the 
amplification step was performed according to methods at EmbryoGENE 
(Vallée et al., 2009; Gilbert et al., 2010). 
For labelling, the Universal Linkage System by Kreatech (Leica 
Microsystems, ON, Canada) for Agilent microarrays was applied, and 2 l of 
CY3-ULS (green) and CY5-ULS (red), respectively, were added to 2 g of 
aRNA derived from the treated or control sample. Non-reacted ULS-label was 
removed using the Picopure RNA Isolation Kit (Life Technologies, ON, 
Canada). The final aRNA concentration and the efficiency of labelling was 
checked using Nanodrop before hybridization. 
3.4.3 Hybridization of aRNA to Agilent oligo microarray slides 
For each of the colours, 825 ng labelled linearly amplified aRNA was used. The 
microarray hybridization chamber was loaded according to the manufacturer’s 
instructions, and slides were hybridized at 65°C for 17 h. The slides were then 
washed four times in different buffer solutions. 
3.4.4 Microarray data analysis of the transcriptome 
The spotted slides were scanned with a PowerScanner (Tecan, Mannedorf, 
Switzerland), and feature extraction was performed using Array-pro 6.3 (Media 
Cybernetics, Bethesda, MD, USA). Intensity files were analysed using 
FlexArray (Genome Quebec, Montreal, Canada) as described by (Blazejczyk et 
al., 2007). Raw fluorescence intensity data were corrected by background 
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subtraction, Loess normalisation within arrays, and quantile normalisation 
between arrays. Data were analysed using Ingenuity Pathway Analysis (IPA) 
(Qiagen, Redwood City, CA, USA) by constructing pathways and gene 
interaction patterns affected by insulin treatment. 
3.4.5 RT-qPCR validation of candidate genes 
Validation of microarray results was performed by reverse transcribed 
quantitative PCR (RT-qPCR) at the EmbryoGENE platform. RNA was 
transformed into cDNA using the Qscript Flex cDNA kit (Quanta Biosciences, 
Gaithersburg, MD, USA) and an oligo-dT according to the manufacturer’s 
instructions. Specific primers for each selected gene were designed using 
PrimerQuest (Integrated DNA Technologies, Coralville, IA, USA).  
RT-qPCR was performed using a LightCycler 480 system and SYBR Green 
I Master mix (Roche Diagnostics, Laval, Canada). To confirm the specificity of 
each pair of primers, the amplicons were electrophoresed on an agarose gel, 
purified, and sequenced. A standard curve consisting of five points of the PCR 
product for each of the primer pairs diluted from 1 pg to 0.1 fg was used for real-
time quantification of the PCR output. Data analysis was performed using 
LightCycler 480 Software 1.5.0 SP4 (version 1.5.0.39) with the second-
derivative maximum analysis method. Data normalisation used the GeNORM 
normalisation factor (Biogazelle, Gent, Belgium) from the expression of the two 
ȕ-actin (ACTB) and beta-2-microglobulin (B2M) housekeeping genes. PCR 
conditions, primer sequences, product sizes, annealing temperatures, and 
accession numbers are shown in Papers II and III. 
3.5 Lipid profile by desorption electrospray ionization 
mass spectroscopy (DESI-MS) 
The BC8s were individually frozen in 2 L of PBS supplemented with 0.1% 
PVA and shipped on dry ice from the Swedish University of Agricultural 
Sciences (Uppsala, Sweden) to Purdue University (West Lafayette, IN, USA; 
USDA permit 126609 Research).  
A Thermo Scientific LTQ (San Jose, CA, USA) mass spectrometer was used 
for the experiments. The DESI spray had 5 kV applied to the stainless steel 
needle syringe delivering the solvent spray, and nitrogen gas pressure was set at 
160 psi. The capillary temperature was set to 275°C. For the detection of positive 
ions, acetonitrile doped with 10 g/mL Ag2NO3 was used as the solvent system. 
The solvent flow rate was 8 L/min. The instrument injection time was 100 ms, 
with automatic gain control turned on. For the detection of negative ions, 
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dimethylformamide/acetonitrile (1:1 v/v) was used as the solvent system. The 
flow rate was 1.5 L/min, and the instrument injection time was 750 ms, with 
automatic gain control turned on. The number of averaged microscans was three 
and the mass range was 200–1000 m/z. the capillary voltage and tube lens 
potentials were –50 V and –25 V, respectively. MS/MS analysis (by product ion 
scan) was performed to confirm the lipid identification. Information from 
previous publications using DESI-MS analysis of bovine embryos with high-
resolution MS was also used for lipid identification (González-Serrano et al., 
2013; Pirro et al., 2014). 
3.6 Statistical analysis 
3.6.1 Developmental rates, morphological analysis, and cell counts 
The effects of insulin treatment during maturation on developmental rates 
(cleavage and blastocyst development on Day 7 and 8) were studied by analysis 
of variance (ANOVA). The PROC GLM procedure of SAS version 9.2 (SAS 
Institute Inc., Cary, NC, USA) was used, and the results were analysed following 
the arc sinus ¥p transformation of the initial percentages. The results were 
weighted for the number of oocytes per batch. Post-ANOVA multiple 
comparisons were realised either by using the Scheffé adjustment and/or contrast 
options available under GLM. In the last case, the contrast option was used to 
compare the two treated groups together (INS0.1+INS10) to the control (INS0). 
The significance level was set at p < 0.05. For better readability, results are 
presented as the least squares mean ± s.e.m. of untransformed percentages. 
Similar procedures were used to analyse the effects of insulin treatment on gross 
morphology in terms of embryo stage and quality grade. Nonsignificant main 
effects or interactions were removed, and adjusted estimates from the final 
model are presented. Morphological response variables (ACTIN, MITO, and 
MitoC categories) were first analysed by log linear models while using the three 
initial response categories. In order to obtain sufficient numbers of observations 
in each box of the contingency tables data, morphological variables belonging 
to class 2 and 3 responses were merged, and the variables were analysed as a 0/1 
response. Percentages of observations belonging to the class 1 response (the best 
morphological appearance) corresponding to significant effects are presented. 
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3.6.2 Microarray 
An empirical Bayes moderated t-test and the ‘limma’ package in R were used to 
search for differentially expressed genes between the control and INS0.1 and 
INS10 groups (Smyth Gordon K, 2004). The EmbryoGENE microarray 
platform’s designed pipeline was used to obtain a large-scale comparison 
between the insulin-treated groups and INS0 controls for transcriptome (Robert 
et al., 2011) and epigenetics (Shojaei Saadi et al., 2014) analyses. A positive or 
negative fold-change of >1.5 with p < 0.05 was set as the definition for 
differentially expressed transcripts (DETs). 
3.6.3 RT-qPCR 
Differences in gene expression between the INS0 and the INS0.1 groups and 
between the INS0 and the INS10 groups were compared by unpaired t-test 
(Prism 5; GraphPad Software Inc., La Jolla, CA, USA) after log transformation 
of the data. Differences in expression were considered as significant at one-tailed 
p < 0.05.  
3.6.4 DESI-MS 
For each sample, a list of m/z values and ion abundances (after background 
subtraction) from averaged mass spectra was imported into Matlab (The 
MathWorks, Inc., Natick, MA), and principal component analysis (PCA) was 
performed by means of in-house Matlab routines. The full-scan mass spectra 
over the mass range m/z 650–1400 were structured with 9,000 variables. The 
first PCA was performed on a data set of 63 rows (i.e. samples) and 9,000 
columns (i.e. m/z variables).  
All MS spectra were normalized by the standard normal variate 
transformation, correcting for both baseline shifts and global intensity variations, 
and then centred according to category column in order to minimize differences 
due to pooling. Fisher weight was calculated with PCA in order to estimate the 
discriminative ability, i.e. the ability to separate the two categories. Because 
lipids in the lower mass region are inherently less important in describing the 
separation among the samples, which is because the signal intensity of the ions 
under m/z 850 is much lower, we separately evaluated lower and higher mass 
ranges to balance their contributions. As an alternative procedure, the mass 
spectrum of each sample was divided into a low (m/z 650–900) and high (m/z 
901–1400) mass range. The two blocks of data were processed by PCA with a 
mid-level data fusion strategy because they were two independent sources of 
information collected from the same samples (Pirro et al., 2014). Individual 
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PCAs were performed on the two blocks of data, after normalization and 
category column centring, and the first six principal components were fused with 
a mid-level strategy and PCA was performed again with auto-scaled column 
data. 
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4.1 Method validation study of in vitro insulin exposure 
(Paper I) 
The main objective of this work was to investigate the possible effects that an 
insulin challenge during in vitro oocyte maturation has on the developmental 
potential of the derived embryos. This experimental design was developed with 
the aim of mimicking the situation during metabolic imbalance such as that 
which occurs due to hyperinsulinemia and/or insulin resistance.  
Reproductive disorders linked to hyper-or hypoinsulinemia are common in 
dairy cows, and one reason for impaired fertility of overfed or thin animals is 
decreased oocyte quality and thus impaired embryo developmental 
potential(Adamiak et al., 2005a; Awasthi et al., 2010). To be able to understand 
the pathophysiological mechanisms during in vivo metabolic challenges, in vitro 
models are good tools to discover possible changes in the early embryo.  
To further define the model and experimental set up, literature about 
measured insulin concentrations in serum and follicular fluid and commonly 
used insulin concentration in in vitro studies was reviewed. This was done in 
order to identify the differences between the in vitro and in vivo situation and to 
be able to design the studies in a way that would respect the special situation of 
an in vitro model while still allowing conclusions with physiological relevance 
in vivo. We discovered a large discrepancy between the in vivo and in vitro 
situation, and the applied in vitro insulin concentrations were 100 to 1000-fold 
greater in vitro than in vivo concentrations (Laskowski et al., 2016a and Paper 
I). One of the reasons for insulin supplementation at supra-physiological levels 
is the possibility that insulin is unstable in vitro due to media containing cysteine 
(Hayashi et al., 1978). On the other hand, researchers might use insulin for its 
anti-apoptotic and proliferative actions without taking into account that there 
4 Main results and discussions 
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might be a negative influence on the embryo growing under metabolic stress 
conditions such as hyperinsulinemia. The reason for the elevated doses of insulin 
might be that this anti-apoptotic and proliferative effect (Byrne et al., 2002) is 
transmitted through the IGF-1 receptor (Rubin & Baserga, 1995), that also binds 
insulin but with a lower affinity (Le Roith, 1997; Fürstenberger & Senn, 2002, 
Figure 8). Thus, in the presence of elevated doses, insulin might mainly act 
through the IGF-1 receptor. However, the reported results are contradictory and 
both beneficial as well as detrimental effects of IGF-1 action during early 
embryo development have been reported (Herrler et al., 1992; Chi et al., 2000; 
Spanos et al., 2000; Byrne et al., 2002; Makarevich & Markkula, 2002; Block 
et al., 2008). 
 
Figure 8. Binding of circulating insulin and IGFs to target cells. Insulin and IGF1 receptors are 
structurally homologous and are both tyrosine kinases. IGF2R differs structurally from the insulin 
receptor and IGF1R and is thought to function primarily as a scavenger receptor for IGF2. Insulin 
binds to its own receptor and to IGF1R. IGF1 and IGF2 bind to the insulin receptor. The relative 
affinities of ligands are indicated by the width of the arrows in the upper part of the diagram. 
(Reproduced with permission from Le Roith, 1997, Copyright Massachusetts Medical Society). 
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Because of their structural similarity, activation of the insulin receptor and IGF-
1 receptor lead to similar responses on the cellular level, but their post-receptor 
pathways differentiate by transmitting metabolic functions through the insulin 
receptor and growth and differentiation functions through the IGF-1 receptor (Le 
Roith et al., 1995; Le Roith, 1997). 
With our work, we wanted to contribute to a better understanding of insulin-
induced actions at the post-receptor level by investigating the gene expression 
of the embryo and, together with developmental rates and morphology, to 
present an overall picture of possible mechanisms that change the phenotype of 
an embryo derived from hyperinsulinemic conditions during oocyte maturation. 
This might help to better understand pregnancy losses and subfertility in animals 
suffering from both types of ketosis. Moreover, the programming of  metabolism 
during early development might have consequences for subsequent generations 
of dairy cows, a fact that illustrates how important fundamental research on 
embryo quality is. Genetic selection and breeding goals already include health 
parameters in the cow, and this could also include breeding for improved 
resistance against metabolic disorders. Nevertheless, the changes that are 
observed in the embryos originating from elevated insulin during maturation 
highlight the need to maintain metabolic balance in the maternal organism so as 
to obtain metabolically healthy offspring. 
In our model, we chose to use two different insulin doses, 10 g/ml and 0.1 
g/ml, to cover both a typical in vitro concentration and to reduce one of the 
doses to a level closer to physiological concentrations but still suitable under in 
vitro conditions. The results of our pilot study showed evidence that insulin is 
still detectable after 22 h of maturation, and the concentrations did not seem to 
differ between empty and COC-incubated media, and in none of the samples was 
the insulin entirely consumed by the COCs (Paper I). 
The limitations of this study were the small number of samples that did not 
allow advanced statistics and the need to dilute the samples down to the 
measurement range of the ELISA (0.05–3.0 ȝg/L), which could have led to 
inaccuracies of the analysis. Mercodia Bovine Insulin ELISA (10-1201-01) is a 
solid-phase two-site enzyme immunoassay based on the sandwich technique, in 
which two monoclonal antibodies are directed against separate antigenic 
determinants on the insulin molecule (www.mercodia.com). This does not allow 
conclusions about the insulin activity itself, but we could validate that our added 
concentrations were detectable and that the difference between both insulin 
groups remained throughout maturation. Further dose-dependent studies would 
be interesting to define a minimum dose in vitro in order to avoid the negative 
effect of hyperinsulinemia during early development. 
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4.2 Influence of insulin on development rates (Paper II 
and III) 
The objective of recording developmental rates and characteristics of important 
events during early development was to detect possible differences in 
developmental potential of the embryos before further studying them through 
gene expression and morphological analyses.  
In all of the different sub-studies, the general tendencies in developmental 
rates were similar and repeatable (Table 2). There was no difference observed in 
cleavage rate between the control and insulin groups, but there were significantly 
lower blastocyst rates on Day 8 in the insulin-treated groups compared to the 
controls.  
Early cleavage is usually reported to be a sign of high developmental 
competence, and early cleaved embryos have a higher chance to develop into the 
blastocyst stage (Plante & King, 1992; Plante et al., 1994; Andra et al., 1999; 
Lonergan et al., 1999). Because we could not observe any difference in cleavage 
rates between any of the groups, but did see a decreased BC8 rate, the possible 
negative effect of insulin seems to impair the development at a later stage rather 
than having an immediate effect. Considering the time of activation of the 
embryonic genome, early cleavages probably depend on the oocyte, and these 
mechanisms do not seem to be affected by insulin. On the contrary, disturbances 
induced by insulin might affect oocyte quality in such a way that EGA is 
impaired, but these effects are not critical because the differences in the 
development rates are quite small. 
Table 2. Number of oocytes, cleavage rate, and blastocyst rate on Day 8 (BC8) in the INS0 
untreated control group, the INS0.1 oocytes exposed to 0.1 g/mL insulin during maturation, and 
the INS10 oocytes exposed to 10 g/mL insulin during maturation.  
Table modified from Paper II *and IIIº. 
Treatment No. oocytes  Cleavage rate A (%) BC8 A, B (%) 
INS0º 1079 80.64 23.8 ± 1.3 
INS0.1º 1019 78.86 20.4 ± 1.3 
INS10º 984 80.91 19.8 ± 1.3 
INS0* 695 78.64  20.29 ±0.02 
INS0.1* 662 76.92  16.29 ±0.02 
INS10* 669 79.82 15.97±0.02 
A Cleavage and blastocyst rates show cleaved embryos and blastocysts as a percentage of immature oocytes. 
B º p <0.03 and *p<0.07 for the comparison of the INS0.1 and INS10 groups combined versus the INS0   
     group. 
 
It was evident that blastocyst development was best in the control group and that 
the insulin-treated groups showed more similarities between each other than 
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compared to the controls; nevertheless, the highest insulin concentration had the 
lowest BC8 rates (Table 2). The underlying reasons for the lower survival will 
be further discussed in chapters 4.3 to 4.5. However, the most plausible 
hypothesis is that the hyperinsulinemic conditions during oocyte maturation 
imply metabolic stress at the cell level with an increased presence of oxidative 
stress-related metabolites that lower embryo viability.  (Facchini et al., 2000a; 
Guerin et al., 2001; Ceriello & Motz, 2004).  
The period of oocyte maturation and early development takes place during 
the most stressful phase of metabolic imbalance because cows usually return to 
breeding around 60 days postpartum. This means that the oocyte has gone 
through several metabolic conditions during the time between follicular growth 
and final maturation with periods of NEB and PEB (Wattiaux, 1996). The in 
vitro model allows for investigations of the embryonic development under 
stressed conditions, even if it is not the perfect model for the in vivo situation 
where several more metabolites and hormones interact in the system.  
A moderate level of embryo metabolism has been suggested to be more 
beneficial for long-term survival than extremely low or high levels of 
metabolism (Baumann et al., 2007; Leese et al., 2007), a fact that should be 
considered when assessing and selecting large and fast developing embryos as 
the best ones. Hyperinsulinemia during oocyte maturation might lead to insulin 
resistance in the early embryo and thus to impaired signalling pathways and 
impaired post-receptor mechanisms and consequently to impaired ability for the 
embryo to balance its energy homeostasis. It is well known that foetuses from 
obese mothers can develop insulin resistance in utero (Catalano et al., 2009), 
and it has become evident that pathological mechanisms could already be set in 
the preovulatory oocyte and in the preimplantation embryo (Jungheim & Moley, 
2008).  
In conclusion, the observed developmental rates – together with the results 
from the gene expression and morphology studies – fit well into the picture that 
hyperinsulinemia decreases the developmental competence of the embryo. 
Explanations for the impaired developmental capacity due to hyperinsulinemia 
will be discussed in the following chapters. 
4.3 Insulin and embryo morphology (Paper II and III) 
Gross morphology evaluation of developmental stage and embryo quality 
grade did not show any significant differences between the groups. Nevertheless, 
when investigating the cytoskeleton and mitochondria quality in detail by 
confocal microscopy after staining, the phenotypes of the insulin and control 
groups showed some distinctions. In general, the two insulin groups showed 
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higher similarity to each other than to the control group in all morphological 
parameters. The main findings were an increased nuclei number in the insulin 
groups and that the actin and mitochondria categories that are associated with 
better quality were more common in the insulin groups compared to controls 
(Table 3, Paper II and III).  
Table 3. Number of nuclei (TN= total number) and actin and mitochondria categories (% of 
category 1 of all embryos of the same group) in insulin-treated (INS0.1 and INS10) and control 
(INS0) groups. Table modified from Paper II* and IIIº 
Group MITO1 % MitoC1% ACTIN1% NUCLEI TN* NUCLEI TNº 
INS10 52.00  a 50.00  a 32.65 a 101 a 101 a 
INS0.1 47.37  a 55.36  a 38.60 a 104 a 100 a 
INS0 23.73  b 30.51  b 20.00 b   86 b   93 b 
a/b p<0.05. 
While there is evidence that differences in the phenotypes of embryos between 
the groups exist on a microscopic level, the interpretation of the findings is more 
complex. For the number of nuclei, the most logical explanation seems to be the 
previously described proliferative actions of insulin (Draznin, 2009). The 
embryos derived from insulin-supplemented conditions grow faster and become 
larger in the same time period, while the control groups lay “behind” them in 
development. Because we observed increased BC8 -rates in the control group, it 
is probable that this enhanced development in the presence of insulin implies 
stress and thus a higher risk for embryonic death or developmental block, fitting 
with the “quiet embryo hypothesis” (Leese, 2002). This in contrast to the opinion 
that the faster-growing embryos have an advantage in developmental 
competence (Van Soom et al., 1997; Luna et al., 2008). The positive relationship 
between high cell number and developmental potential is based on the finding 
that in vivo embryos, with a generally better viability, have higher cell numbers 
compared to their in vitro counterparts (Iwasaki et al., 1990). Primarily, this 
implies that the embryos with higher cell numbers have already advanced to a 
later stage. Interestingly, we can exclude this “bias” in our studies because no 
significant difference in terms of embryo stage or grade or in stage-related gene 
expression could be observed (Paper III, Rekik et al., 2011).  
One other possibility that has to be considered is that in the insulin-treated 
groups only the strongest and “best” embryos survived, meaning that the 
selection mechanism based on the insulin stress condition leads to fewer 
surviving embryos, but those that do survive are of better average quality. The 
control group generated more embryos in total, but these included a wider 
quality range because the weaker ones were able to survive.  
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In summary, we conclude that the increased cell number of the developing 
embryos after insulin treatment is not explained by advanced developmental 
stage, but more probably implies increased proliferation within a respective 
stage.  
The evaluation of the actin cytoskeleton revealed better actin quality in the 
insulin-treated groups (Table 3 and Paper II) with the highest percentage of 
ACTIN1 in the INS0.1 group. One reason for the obviously more frequent 
categorizing of the INS0.1 and INS10 embryos in the good actin quality category 
could be that the mitogenic effects of insulin mean that only embryos able to 
cope with this metabolic stress survive, and thus better actin quality is observed 
compared to the non-insulin-treated control embryos. Because the INS0.1 group 
showed the best actin quality, the proliferative and mitogenic stimuli might 
dominate in the more moderate insulin concentration compared to the more 
extreme hyperinsulinemic concentration of INS10, but this observation did not 
reach significance (Table 3). 
Another interesting idea is that the higher proportion of high-quality actin 
categories in the insulin-treated groups might be explained by the fact that actin 
plays an important role in insulin signalling in the post-receptor pathways – 
insulin is reported to have effects on cell morphology by inducing rapid 
reorganization of the actin cytoskeleton because this is necessary for 
transmitting the different effects of the insulin signal (Tsakiridis et al., 1994, 
1995, 1999). This fits well with our observations that the actin structure in 
general seems to be better distinguished and thus to be scored higher in the 
insulin-treated embryos compared to the controls. The insulin-induced 
modifications that are “activated” by actin are reported to lead to structures 
beneficial for the association of PI3-K (p85) with GLUT4 vesicles and perhaps 
also for the transport of GLUT4 to the cell surface (Khayat et al., 2000; 
Shibasaki et al. 1994). This would explain why higher proportions of better-
structured embryos are found in the two insulin groups, with the most favourable 
actin profile in the lower and more moderate insulin concentration. 
Interestingly, we could also show that the probability to be assigned the best 
actin quality category increased with embryo stage, independent of insulin 
treatment (Paper II). This fits with the hypothesis that more advanced stages 
and more actively proliferating embryos possesses better actin quality. While the 
reasons for the different actin pattern need to be further elucidated, it is clear that 
the insulin treatment induces a different actin phenotype than observed in 
controls and that this phenotype might resemble embryos of further progressed 
stages. These results also support the hypothesis that only the best-quality 
embryos were able to survive the insulin challenge, which leads to a narrower 
distribution of actin quality compared to the controls. This theory is based on the 
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fact that blastocyst rates are lower in the insulin-treated groups, perhaps due to 
the fact that embryos with lower developmental potential only survive under less 
stressful conditions. 
For the two classes of mitochondria quality – MITO and MitoC – a similar 
trend as for the actin assessment could be observed, and the percentages of both 
categories were higher in the insulin-treated groups and, independently of insulin 
treatment, for more advanced embryo stages. This confirms the hypothesis that 
has been set according to the actin and cell number evaluations, postulating that 
the insulin treatment during in vitro maturation leads to a phenotype of 
accelerated development due to the metabolic and mitogenic actions of insulin 
(Shepherd et al., 1998; Bevan, 2001).  
In the morphological evaluation of the active mitochondria, the best category 
was characterised as the most distinguished mitochondrial pattern, and here too 
the prominent, active mitochondria might be a signature of a highly 
metabolically active embryo, and a more moderately active embryo could be 
more viable in the long run. Because mitochondria are the energy-providing 
organelles, their function is important for many processes during early 
development such as differentiation, mitosis, and molecular transport (Barnett et 
al., 1996; Båge et al., 2003; Bruce Alberts et al. 2002). Active mitochondria and 
their distribution is a good predictor for embryo viability (Barnett et al., 1996; 
Tarazona et al., 2006; Van Blerkom, 2008). Because hyperinsulinemic 
conditions such as those seen in obesity and type 2 diabetes are associated with 
mitochondrial damage and oxidative stress (Facchini et al., 2000b; Morino et 
al., 2006), our morphological observations could, together with the gene-
expression data, help to better understand the relation between insulin, oxidative 
stress, and mitochondrial distribution and functions.  
To better understand the clinical relevance of these results, it would be 
interesting to transfer embryos on Day 7 or 8 to a recipient heifer and look at 
later developmental stages to determine if the changes are transient or if they 
remain in the growing embryo, foetus, or even in the new-born and adult stages. 
4.4 Insulin and embryo gene expression (Paper II, III, IV) 
4.4.1 General transcriptome patterns of the embryo and the most 
relevant pathways activated by insulin during oocyte maturation 
(Paper III) 
Analysis of gene expression in insulin-treated versus control groups resulted in 
156 differentially expressed transcripts (DETs) in the INS0.1 group and 229 
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DETs in the INS10 group with an overlap of 120 DETs (Paper III). For most of 
the genes, a greater fold-change was observed in the INS10 than INS0.1 group, 
showing a more pronounced effect of insulin on gene expression following 
maturation in the presence of the higher insulin concentration. The global 
transcription pattern of embryos developing after insulin treatment during oocyte 
maturation exhibited an overall increase of gene expression with only four 
(INS0.1) and five (INS10) genes displaying significantly decreased mRNA 
levels. The most relevant pathways associated with the DETs were 
growth/chromatin structure, steroid/cholesterol metabolism, energy supply, NF-
E2 p45-related factor-2 (NRF2)-mediated oxidative stress response, cell cycle, 
cellular compromise, lipid and carbohydrate metabolism, and cellular assembly 
and organisation.  
Representative genes of each pathway were validated by RT-qPCR (Paper 
II, III, IV) with a concordance of 80% with the microarray data. It was obvious 
that the insulin-treated groups were more similar to each other than to the 
controls and that in the lower insulin concentration the proliferative actions and 
influences on cell cycle were more prominent, while in the INS10 group signs 
of cellular compromise and impaired metabolic functions were detected (Table 
4). As previously described by several authors (Cagnone et al., 2012; Cagnone 
& Sirard, 2013; Van Hoeck et al., 2015), other metabolic stress conditions such 
as hyperglycaemia and elevated NEFAs and serum lipids can affect the 
transcriptome of embryos.  
The use of two different insulin concentrations and the large scale analysis 
of transcriptome differences showed that candidate genes involved in apoptosis, 
differentiation, and metabolism of the BC8 were regulated by insulin. The 
hypothesis that hyperinsulinemic conditions during maturation increase the 
growth of the embryo at the expense of decreased viability is further supported 
by the observation of multiple changes on the transcriptome level. The DETs 
related to energy metabolism, differentiation, the oxidative stress response, and 
mitochondrial activity were expected because the functions of their encoded 
proteins fit well with the described actions of insulin in health and disease 
(Facchini et al., 2000b; Saltiel & Kahn, 2001; Bloch-Damti & Bashan, 2005). 
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Table 4. Influence of 10 g/ml (IN10) and 0.1 g/ml insulin (INS0.1) during oocyte maturation on 
gene expression. The p-value range and the number of molecules with a fold-change >1.5 after 
insulin treatment are based on microarray analysis and are grouped according to cellular function 
in Ingenuity Pathway Analysis (Laskowski et al., 2016b). 
 
Cellular functions  p-value    
range 
Number of 
molecules  
Example genes 
INS10:    
Cell Cycle 
 
1.49E-05 – 
2.78E-02  
   23 LMNA, SOX2, VIM, 
MAP2K2 
Cellular Compromise 2.59E-04 – 
2.78E-02   
   15 KEAP1, VIM, LMNA 
Lipid Metabolism   2.83E-04 – 
2.78E-02  
   20 APOA1, CYP11A1, 
INSIG1, VIM, DHCR7 
Molecular Transport 
 
2.83E-04 – 
2.78E-02  
   19 APOA1, CYP11A1 
Small Molecule Biochemistry 2.83E-04 – 
2.78E-02 
   30 APOA1, CYP11A1, 
INSIG1, IGF2R 
INS0.1:    
Cell Morphology 8.28E-05 – 
2.00E-02 
   29 CD81, VIM, LMNA 
 
Cellular Growth and 
Proliferation 
8.28E-05 – 
2.16E-02 
   63 ADIPOR2, IGFBP7 
Cell Cycle 1.70E-04 – 
1.82E-02 
   25 SOX2, LMNA, IGFBP7 
 
Carbohydrate Metabolism 2.47E-04 – 
1.95E-02 
    9
  
APOA1 
 
Cellular Assembly and 
Organization 
2.47E-04 – 
1.82E-02 
   22 VIM, LMNA 
 
ADIPOR2 = Adiponectin receptor 2; APOA1 = Apolipoprotein A 1; CD81 = Cluster of differentiation 81; 
CYP11A1 = Cytochrome P450 family 11 subfamily A, DHCR7 = 7-Dehydrocholesterol reductase; IGFBP7 = 
Insulin like growth factor binding protein 7; IGF2R = Insulin like growth factor 2 receptor; INSIG1 = Insulin-
induced gene 1; KEAP1 = Kelch like ECH associated protein 1; LMNA = Lamin A/C; MAP2K2 = Mitogen 
activated protein kinase kinase 2; SOX2 = Sex determining region Y box 2; VIM = Vimentin. 
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4.4.2 Signatures of an impact of insulin on embryo lipid metabolism 
(Paper IV) 
Downstream analysis of the insulin-induced transcription factors peroxisome 
proliferator-activated receptor (PPAR) and sterol regulatory element binding 
protein (SREBP/SREBF) revealed significant fold changes of downstream genes 
of each of these transcription factors. The effect on genes regulated by PPARĮ 
was stronger in INS10, with 14 genes with significant fold changes compared to 
INS0.1 with 10 genes with significant fold changes, and 10 more DETs regulated 
by PPARڸ were found to be over-expressed in INS0.1. The downstream analysis 
of SREBF1 and 2 in the INS10 group revealed that transcripts of 7-
dehydrocholesterol reductase (DHCR7), fatty acid desaturase 2 (FADS2), insulin 
induced gene 1 (INSIG1), mevalonate diphosphate decarboxylase (MVD), and 
heat shock protein family A (Hsp70) member 1 (HSPA1A/HSPA1B) – all of 
which are crucial for cholesterol and steroid synthesis – were more abundant. 
Cholesterol metabolism in the BC8 – with its important function for steroid 
synthesis – was influenced on multiple levels in both insulin treatments (Table 
5).  
All observed differences as described in detail in Paper IV, show a strong 
impact of insulin on lipid metabolism in the BC8 and reflect  insulin’s previously 
described functions in both  physiological and pathological conditions (Saltiel & 
Kahn, 2001; Kahn et al., 2006). Because cholesterol has important functions 
during development (Farese & Herz, 1998), dysregulation of related pathways 
might have detrimental effects on the developmental competence of the embryo. 
Signatures of lipid accumulation, pathways preventing such accumulation, and 
increased transcription of genes associated with oxidative stress are other signs 
of the significant impact of hyperinsulinemic conditions, even several days after 
exposure.  
The impact of insulin on lipid metabolism in the embryo is interesting 
because this shows similarities to the dysregulation of the metabolism of adult 
cows where both hyper- and hypoinsulinemia lead to the accumulation of lipids 
in the circulation, either through alimentary energy excess or increased 
mobilisation of body fat reserves. Thus metabolic challenges early in life could 
cause a certain metabolic fragility later in life as well and lead to animals that 
are less able to cope with metabolic stress. 
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Table 5. Cholesterol-related genes with significant p-value (p<0.05) and fold change differences 
in INS10 (a) and INS0.1 (b) compared to INS0, sorted according to their function in lipid 
metabolism. 
Function/Pathway        p-value DETs 
a) INS10:   
Accumulation of cholesterol            2.83E-03   ACP5, IGF2R, INSIG1,   
 LAMP1,NR1H2 
Mobilization of cholesterol          5.14E-04    APOA1, NR1H2 
Metabolism of cholesterol                      5.31E-04    APLP2, APOA1, CYP11A1,    
 DHCR7, INSIG1, NR1H2        
Absorption of cholesterol          5.72E-03  APOA1, NR1H2, PNLIP 
Homeostasis of cholesterol          6.42E-03       APOA1, DHCR7, EHD1, 
NR1H2                        
Steroid metabolism                            8.21E-03       ACAA1, APLP2, APOA1,   
 CYP11A1, DHCR7, INSIG1,  
 NR1H2, VIM 
Storage of cholesterol          8.41E-03  EHD1, NR1H2 
Cleavage of cholesterol          9.34E-03  CYP11A1 
Recruitment of cholesterol          9.34E-03  APOA1 
Efflux of cholesterol ester          1.86E-02  APOA1 
Accumulation of cholesterol ester          2.26E-02  INSIG1, NR1H2 
Synthesis of cholesterol          2.29E-02  APOA1, DHCR7, INSIG1 
b) INS0.1:   
Mobilization of cholesterol          4.91E-04  APOA1, NR1H2 
Steroid metabolism                            7.18E-03       ACAA1, APLP2, APOA1.   
 COMT, DHCR7, NR1H2,    
 NR3C1, VIM 
Recruitment of cholesterol           9.13E-03  APOA1 
Metabolism of cholesterol          1.72E-02  APLP2, APOA1, DHCR7,   
 NR1H2 
Depletion of cholesterol ester          1.82E-02  APOA1 
Efflux of cholesterol ester          1.82E-02  APOA1 
Accumulation of cholesterol          1.91E-02  IGF2R, LAMP1, NR1H2 
 
ACAA1 = Acetyl-CoA acyltransferase 1; ACP5 = Acid phosphatase 5; APLP2 = amyloid precursor-like protein 
2; APOA1 = Apolipoprotein A 1; COMT = Catechol-O-methyltransferase; CYP11A1 = Cytochrome P450 
family 11 subfamily A member 1; DHCR7 = 7-Dehydrocholesterol reductase; EHD1 = EH domain containing 
1; IGF2R = Insulin-like growth factor 2 receptor; INSIG1 = Insulin induced gene 1; NR1H2 = Nuclear receptor 
subfamily 1 group H member 2; NR3C1 = Nuclear receptor subfamily 3 group C member 1; PNLIP = Pancreatic 
lipase; VIM = Vimentin. 
 
4.5 Insulin and embryo lipid profile (Paper IV) 
 
Following up on the results of the transcriptome study (4.4), a deeper analysis 
of the lipid metabolism-related effects on gene expression was performed in 
Paper IV, illustrating the context and possible correlations between DETs.  
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A chemical lipid profile of BC8 was performed via DESI-MS with the aim 
of detecting possible differences in the lipid content of the embryos. In summary, 
the lipid profile analysis revealed slightly downregulated mitochondrial 
metabolism in response to an insulin challenge (Paper IV, as shown by 
ubiquinone abundance). Moreover, insulin only impacted triacylglycerid and 
cholesteryl ester abundance to a limited extent. The cholesterol metabolism in 
embryos derived from insulin-exposed oocytes seems to be influenced to some 
extent because the control embryos had higher levels of squalene, a cholesterol 
precursor, along with higher levels of cholesteryl esters of palmitoleic and oleic 
acids. 
Interestingly, the results from the lipid profiling did not show such large 
differences as the lipid gene expression between insulin-treated embryos 
compared to controls. However, other studies revealed stronger differences with 
the same methods, e.g. between in vitro and in vivo embryos (González-Serrano 
et al., 2013) and between mature and immature oocytes (Pirro et al., 2014) . 
The results of gene expression and lipid profiling led us hypothesise that the 
embryo might be able to compensate for the insulin challenge by trying to sustain 
a stable chemical profile, although the lipid-related gene expression reveals 
signatures of metabolic stress. Some of the gene expression changes were going 
in both directions – e.g. there were signs of increased lipid accumulation together 
with signs of countermeasures against such accumulation (Figure 9). Moreover, 
it has been reported that in vitro culture downregulates cholesterol metabolism 
(González-Serrano et al., 2013). Because this study was in vitro-based, the 
embryos might have been unable to translate the gene expression changes into 
cholesterol metabolism changes due to limitations imposed by the culture 
system, or because the chemical lipid profile differences would only be 
observable at later embryo stages due to the time gap between gene expression 
observations and phenotypic lipid appearance. However, the lipid profile seems 
to be more stable compared to the observed transcriptome changes, possibly 
because in the first days of development a different lipid composition is 
detrimental for embryo survival.  
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Figure 9. Interactions of insulin-regulated pathways in lipid metabolism. Insulin activates SREBPs 
that regulate pathways linked to lipid accumulation (purple), and it influences fatty acid metabolism 
(SREBP1c) and cholesterol and steroid metabolism (SREBP2). In green are pathways and genes 
acting against lipid accumulation through adiponectin and PPARĮ- related pathways. 
  
FA = Fatty acid, TAG = Triacylglycerid. Genes upregulated by insulin that protect against lipid accumulation: 
APOA1 = Apolipoprotein A 1, ADIPOR2 = Adiponectin receptor 2, HDL = High density lipoprotein, HMGCR 
= 3-Hydroxy-3-methylglutaryl-CoA reductase, INSIG1 = Insulin induced gene 1, LDLR = Low density 
lipoprotein receptor, PPARĮ = Peroxisome proliferator-activated receptor alpha. Genes upregulated by insulin 
that are related to lipid accumulation: CYP11A1 = Cytochrome P450 family 11 subfamily A member 1, DHCR7 
= 7-Dehydrocholesterol reductase, FADS2 = Fatty acid desaturase 2, MVD = Mevalonate diphosphate 
decarboxylase, SCAP = Sterol regulatory element-binding protein cleavage-activating protein, SREBP = sterol 
regulatory element binding protein, VIM = Vimentin. 
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Insulin – a key regulator of energy homeostasis with strong influences on both 
carbohydrate and lipid metabolism – was chosen to investigate the potential 
effects of metabolic imbalance during early embryonic development. Through 
the work performed for this thesis, new insights about and possible explanations 
for the detrimental effects of hyperinsulinemia could be illustrated.  
In summary, this thesis presents a first approach in establishing an in vitro 
model for metabolic imbalance by using elevated insulin conditions during 
bovine oocyte maturation and investigating the effect on the BC8s. 
The results provide a promising base for further research and possible 
improvement of in vitro models of metabolic imbalance. Being a multifactorial 
problem, it would be interesting to combine several factors associated with 
hyperinsulinemia such as glucose, IGF-1, IGF-2, and fatty acids in a refined 
model. Also, it would be interesting to further reduce the insulin levels in in vitro 
studies to avoid the possible negative effects of hyperinsulinemia on the 
developing embryo, as was seen in our studies. 
 
¾ An in vitro model for metabolic imbalance during early development was 
developed based on a comparison of insulin concentrations found in vivo and 
used in other in vitro studies. The model was established and validated. Both 
insulin concentrations led to similar effects with a slightly stronger effect on 
gene expression in the higher insulin dose and a more proliferative effect in 
the lower dose. 
 
¾ In the in vitro model, there was a clear negative impact of elevated insulin 
during oocyte maturation on blastocyst developmental rates, while cleavage 
was not influenced. The mechanisms and underlying reasons for lower 
blastocyst rates of the insulin groups should be further defined and discussed. 
 
 
5 Concluding remarks 
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¾ Evaluation of morphological parameters of the BC8 in terms of total cell 
count, actin structure, and mitochondria distribution pattern showed 
differences between embryos originating from the insulin-treated oocytes 
and the controls. The observed morphological changes could be related to 
different gene expression patterns of genes encoding proteins related to 
proliferation, cellular structures, and mitochondrial stress. 
 
¾ Gene expression patterns in embryos derived from insulin-supplemented 
oocytes showed an overall increase in gene expression and these genes were 
coupled to pathways related to growth and proliferation, lipid and energy 
metabolism, differentiation, the oxidative stress response, and mitochondrial 
activity. 
 
¾ There were significant increases in gene expression of pathways linked to 
lipid metabolism in the insulin-treated groups compared to controls. Lipid 
profile analyses were performed, and the gene expression relations of 
cholesterol and steroid metabolism and lipid accumulation as well as 
mechanisms against such accumulation, were described in detail. 
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With this work, we aimed to contribute to further knowledge about the different 
mechanisms induced by an insulin challenge during bovine oocyte maturation. 
We could answer some questions, but further studies are required to gain 
increased knowledge concerning the complex actions of insulin during 
embryonic development. Several key questions still remain to be answered in 
future studies. 
 
¾ Are commonly used doses of insulin during in vitro cell and embryo culture 
too high? 
 
There is a large variation between in vivo measured and in vitro applied 
insulin concentrations, but no clear explanations have been suggested for this 
gap. Because several effects of elevated insulin during oocyte maturation are 
retained and change the phenotype of the embryo, supra-physiological doses 
of insulin should be used with care. Further studies are necessary to define 
the minimum and maximum dose that can provide the benefits while 
avoiding the adverse effects of insulin in vitro. 
 
¾ How long is insulin active in vitro? 
 
In our model, we validated the presence of insulin after 22 hours of 
maturation by measuring insulin with an ELISA. The weakness of this 
method is that it is a quantitative measurement and does not say anything 
about the activity of insulin after incubation. A detailed study of insulin 
activity in culture medium and possible loss of activity due to medium 
components would be of interest. 
 
 
6 Future perspectives 
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¾ Can the positive effects of insulin in vitro still be achieved using physiological 
doses? 
 
Because insulin has positive effects on proliferation and works as an anti-
apoptotic factor, these potential positive effects could be further explored by 
knowing at what dose the adverse effects in form of increased energy 
metabolism leading to cellular stress begin to appear. Thus, further studies 
using different concentrations of insulin would be interesting. 
 
¾ How does the morphology and gene expression of the oocyte change if it 
matures under insulin supplementation? 
 
Because multiple changes in phenotype and gene expression in embryos 
originating from oocytes matured with insulin supplementation could be 
observed in the present work, another approach would be to investigate the 
matured oocyte immediately after insulin challenge and compare the results 
of oocyte gene expression and morphology with the data we have obtained 
for the blastocyst. 
 
¾ Do the changes in gene expression remain in later embryo stages or even 
after the offspring are born? 
 
In our laboratory studies, we were limited to investigating BC8. Because the 
differences between insulin and control groups were observed 8 days after 
exposure, it is possible that the induced changes might even remain until later 
stages and even after offspring are born. To get a complete picture of the 
possible consequences of hyperinsulinemia in the period around conception, 
later embryo stages should be analysed as well as the offspring. 
 
¾ How does insulin induce epigenetic changes with further consequences for 
the offspring and subsequent generations? 
 
Epigenetic changes are induced by external factors such as the nutritional 
status of the mother, and these are more stable than changes at the 
transcriptome level because they interfere with gene regulation and the 
accessibility of genes for transcription. Epigenetic changes can be transferred 
to subsequent generations, and this explains their importance and potential 
risk. Evidence for the possibility of health problems as adults due to 
metabolic programming early in life has already been shown. Research with 
human embryos is ethically controversial, and thus the comparative aspects 
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of such studies should be further explored in order to obtain better knowledge 
about this potential “inherited factor” of metabolic imbalance. 
 
¾ Can this work contribute to the detection of the most viable embryos for 
transfer? 
 
To determine the long-term consequences of the insulin challenge, the 
embryos should be transferred. Ideally, the embryos would be biopsied 
before transfer, and the expression of genes related to the changes we have 
observed in our study should be studied to see if the gene expression profile 
reliably predicts the later phenotype. However, our present results suggest 
that excess insulin is unfavourable for embryo production under an IVP 
programme. 
 
¾ Do the embryos that survive the insulin challenge have better promise for 
future development because they have better morphological parameters? 
 
At this point, we cannot be sure about the detrimental or beneficial effects of 
insulin supplementation. The morphological findings presented here assume 
a “stronger” phenotype in the insulin-treated groups, while developmental 
rates are decreased and the gene expression pattern shows signs of stress. 
Still, it would be interesting to follow up these embryos to be able to assess 
their future potential.  
 
¾ Would genetic selection for insulin sensitivity of cows also improve the 
metabolic stability of their embryos? 
 
A next step would be a genetic screening of animals for a stable response to 
metabolic challenges because it is already known that differences exist in 
insulin sensitivity among breeds. Once identified, studies could be performed 
with the oocytes collected from good and average cows to test their 
developmental potential under a metabolic challenge in vitro. 
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The content of the thesis is about how metabolic disturbances influence the 
developmental potential of early cattle embryos. Metabolic imbalance is a 
problem in the lactating cow, who has to solve the challenge of adapting her 
metabolism to increasing milk yields, which usually leads to decreased fertility. 
Reproductive health is of large importance in the dairy industry and the aim of 
this work was to improve the understanding of fertility problems in the dairy 
cow. Impaired reproductive performance leads to tremendous economic losses 
for farmers in Sweden and worldwide. Moreover, animal welfare issues due to 
early culling of infertile cows are a problem. 
The early embryo is sensitive to metabolic stress conditions, and decreased 
embryo survival leads to a delay in getting the cows pregnant in time. This is 
why more knowledge about improving the management and physical conditions 
of the cow (the links between fertility, nutrition, milking, and dry period) is 
needed. 
Insulin is an important hormone regulating the body’s energy balance in 
mammals. Insulin concentrations change in situations of energy deficiency or 
excess, and both conditions are known to decrease fertility in cows and as well 
as in humans. 
In humans, metabolic syndrome, obesity, and type 2 diabetes are common 
problems that lead to elevated insulin in the body and to insulin resistance. Cows 
can either get too thin or too fat depending on their energy needs for lactation. 
Both situations can result in decreased fertility, and insulin is involved in the 
regulation of the energy balance. 
In our experiments, we added two different concentrations of insulin during 
the period of oocyte maturation in a laboratory study based on slaughterhouse-
derived oocytes. Developmental rates, morphologies, and gene expression 
profiles of 8 day-old embryos deriving from insulin-treated oocytes were 
investigated. 
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We found that the embryos originating from insulin treatment had a reduced 
survival, and we could observe several phenotypic changes in the embryos. After 
staining and morphological investigations by fluorescence and confocal 
microscopy, we could observe that the total cell number was increased and cell 
actin skeleton structures and organelles were different in the insulin-treated 
groups. This is an indication of differences in the quality of the embryos from 
the insulin-treated groups.  
Moreover, gene expression showed differences, especially in genes related 
to lipid metabolism, cellular stress responses, and growth, which is in alignment 
with previously described and known functions of insulin in health and disease. 
All results taken together showed a clear impact of insulin during early 
development. 
The knowledge obtained through this thesis work contributes to a better 
understanding of the cellular and molecular background that causes lower 
embryo potential due to elevated insulin exposure in the dairy cow. Importantly, 
this work is of comparative value because humans suffering from metabolic 
imbalance also often have decreased fertility. Moreover, it cannot be excluded 
that even the surviving embryos of the insulin treatment could potentially have 
metabolic issues remaining later on in life. 
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Avhandlingen handlar om tidig embryoutveckling hos kor och om hur 
ämnesomsättning i obalans hos modern påverkar embryots utveckling och 
överlevnad. Nedsatt fruktsamhet är ett ökande problem i mjölkkobesättningar. 
Det leder till förlust av djur som har dålig reproduktionsförmåga och 
ekonomiska förluster för bonden. Både kvigor som är för feta och mjölkkor som 
inte klarar energiförsörjningen när mjölkproduktionen sätter igång har ibland 
svårt att bli dräktiga. 
På ett liknande sätt finns det ökande problem med infertilitet på människor 
som ofta också är relaterad till ämnesomsättningssjukdomar som diabetes, fetma 
och insulinresistens.  
Insulin är ett viktig hormon som reglar ämnesomsättningen hos däggdjur. 
Insulinvärdet i blodet kan vara förhöjt hos djur eller människor som är 
överviktiga och det kan leda till insulinresistens och diabetes. Dessutom är 
insulin ett hormon som tillsätts som tillväxtfaktor vid provrörsbefruktning hos 
människa, utan att det är helt klarlagt vad som är lämplig eller skadlig nivå. 
Den tidiga embryoutvecklingen är en väldigt känslig process och embryon 
blir påverkade av miljön de utvecklas i, det vill säga moderns ämnesomsättning. 
För att kunna undersöka vilken effekt olika substanser har kan man göra 
laboratorieförsök med provrörsbefruktning av äggceller. Äggceller samlas från 
äggstockar från slaktade kor på slakteri och befruktas och odlas utanför 
livmodern, en modell som gör det möjligt att undersöka embryon närmare under 
hela utvecklingen. I de studier som avhandlingen är baserad på behandlade vi 
äggceller med två olika, förhöjda nivåer av insulin under äggcellernas mognad 
före befruktningen och studerade sedan embryonas överlevnad, utseende och 
gen-uttryck dag 8 i utvecklingen.  
Vi undersökte hur lång tid det tog för embryon att utvecklas och hur många 
embryon som bildades från äggcellerna, och det visade sig att färre embryon 
utvecklades normalt vid tillsats av insulin. Vi misstänkte att insulinet under 
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äggcellsmognaden orsakade stress på cellnivå och undersökte vidare på vilket 
sätt cellerna påverkades.  
Vi färgade embryona och undersökte dem med hjälp av fluorescens- och 
konfokalmikroskop. Man kunde se att embryonas utseende var annorlunda om 
äggen mognade vid förhöjd insulinnivå. Cellstrukturer som är kopplade till 
energiomsättning (mitokondrier) och cellstabilitet (aktin) var förändrade och 
embryon från de insulinbehandlade grupperna hade fler celler, de hade alltså 
växt snabbare. Utöver det kunde vi visa många förändringar på gennivå. På detta 
sätt försökte vi förstå de molekylära mekanismer som ligger bakom den sämre 
överlevnaden hos embryon som stressats av förändrade förhållanden i moderns 
ämnesomsättning.  Funktioner kopplade till ämnesomsättning, stress, cellväxt 
och fetma var aktiva i högre grad om äggcellen mognade med insulintillsats och 
det kan vara förklaringar till varför färre embryon överlevde i insulingrupperna.  
Våra resultat bidrar till att bättre förstå processerna bakom att embryon har 
sämre överlevnad när moderns ämnesomsättning är i obalans. Eftersom så 
många viktiga kroppsfunktioner anläggs tidigt i utvecklingen finns det en 
potentiell risk att embryon som överlever ämnesomsättningsstress har en 
benägenhet att drabbas av ohälsa senare i livet. Mjölksektorn är beroende av 
friska, fruktsamma kor och det är därför viktigt att förstå sambandet mellan 
ämnesomsättningsstörningar och dålig fruktsamhet.  
Den tidiga embryoutvecklingen hos kor har många likheter med 
embryoutveckling hos människa, och våra resultat kan också hjälpa till att förstå 
möjliga orsaker till infertilitet hos insulinresistenta kvinnor. Genom att använda 
en laboratoriemodell för kor kan man undvika etiska dilemman som annars 
uppstår när man forskar på humana embryon. 
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